2
2
3
4
5
6
I am glad to know that the Indian Pharmaceutical Association - Students’ Forum (IPA SF), the student wing of the Indian Pharmaceutical Association (IPA) is hosting the 61st International Pharmaceutical Students’ Federation (IPSF) – World Congress 2015 at Hyderabad to be held from 31st July 2015 to 9th August 2015. I am happy to note that for the first time ever that India is hosting such a historic World event but also to make it a milestone event of the Indian Pharmaceuticals Association (Students Forum) since its inception in 2008. The International pharmaceutical student federation is the world’s largest professional Organization for budding pharmacists covering 8 0 member countries amongst them Indian students forum has got best students forum award in 2013 and then bid for Congress at Hyderabad. I would like to congratulate the committee including IPA-SF which is a nearby 60 years old organization and gathering of pharmacy professionals from all around the world. I further wish that this occasion provides an opportunity for the best of young professionals in this sector to deliberate and envision a greater commitment to the future of Global Pharmaceutical Opportunities and also explore the Pharmacy education as a holistic experience of learning with innovative pharma. On this occasion, I wish the congress a grand success in experienced pharmacy with innovative learning and I convey my best wishes to all.
7
Dr.P.V.Appaji Director General Pharmaceu cals Export Promo on Council of India (Set up by Ministry of Commerce & Industry,Govt. of India) Hyderabad.
MESSAGE I am extremely happy to learn that Indian Pharmaceu cals Associa on (IPA) has formed “IPA st Students' Forum”, and are organizing "61 IPSF World Congress" at Hyderabad, which would be a great networking opportunity for students to interact and develop their technical skills and knowhow of Pharma Industry. This pla orm would be of mutual benefit to the industry in the search of future pharmacists with professional standards and students in search of good opportuni es. Overseas Pharmacy students would also be benefi ed by understanding more about India as a trusted source for supply of quality gene c medicines at affordable prices . and India as Pharmacy of the World Dr.P.V.Appaji Director General Pharmaceu cals Export Promo on Council of India
8
Dear Par cipant, It is with great pleasure that I welcome you to the 61st IPSF World Congress. The IPSF Execu ve Commi ee is excited about the work IPSF and the Recep on Commi ee of Hyderabad, India, have done over the course of the past two years to organise this extraordinary event. In this booklet, you will find a detailed schedule and informa on of all the scien fic and educa onal symposia, workshops, trainings, compe ons andthe public health campaign. The abstracts of each event, backgrounds of each speaker, and the themes of each social event are here for your convenience. We invite you to engage through the rich experiences of dis nguished speakers for our Scien fic and Educa onal Symposia and to par cipate in our Public Health Campaign,different Professional Development Events and Poster Compe on. Words alone cannot describe the spirit of IPSF, the hospitality of the Recep on Commi ee or the immense beauty and rich history of India. I hope that the informa on provided here will be the guide to the memories you make and the experiences you will gain. Viva la Pharmacie!
Ms. Parand Akhavan IPSF President, 2014-2015
9
Dear Par cipants, Indeed it gives me immense pleasure to extend a warm welcome to the st dis nguished guests and delegates of the 61 IPSF world congress 2015, th th Hyderabad, India to be held from the 30 July to 9 August 2015. st The onus of hos ng this years annual grand event and for the 1 me ever in India is rested upon the IPA-SF. It is an honor to organize such an event during my tenure of Chairperson. IPA-SF par cipates in various ac vi es rela ng to public health, pharmacy educa on and student exchange. IPSF World Congress gives an addi onal opportunity to the members of the associa on to be part of such a big event. It is a pla orm for all to learn the pharma world. The conference aims to focus on strategies for improving quality and feasibility of crea ng a global competency frame work for pharmaceu cal services, presence of high proďŹ le na onal and interna onal pharmacy professionals and young budding pharmacist with innova ve minds which certainly make the IPSF WC an excellent pla orm to discuss ways of moving pharmacy educa on to a more ac ve form. I am conďŹ dent that the conference will provide a perfect venue for informa on exchange and will provide an opportunity for networking among par cipants. It will be an exchange of pharmaceu cal culture. I also guarantee a comfortable and unforge able experience to all of you in Hyderabad, the pearl city of India . I wish a successful delibera on and look forward to the frui ul outcomes of this event. Mr. Rahul Lad
Presient, IPA-SF, 2014-15
10
Chairperson , IPSF-WC,2015 , Recep on Commi ee- Message Our Vision and Mission- IPSF-WC, 2015. Warmest gree ngs from the Recep on Commi ee of the 61st Interna onal Pharmaceu cal Students' Federa on World Congress, 2015 (IPSF WC 2015). Having started this journey in July 2013, we have come a long way and it all circles back to why it started-the 61st IPSF WC 2015, India. The Indian Pharmaceu cal Associa on-Students’ Forum (IPA-SF) and I go a long way back. We first met in 2008-09 when I worked in the editorial commi ee. During my progressive years at IPA-SF, I had the honor of being nominated as the editor and eventually elected as Chairperson of the Recep on Commi ee for this year’s World Congress. Blessed with a team of enthused commi ee members and guidance from the Core members of the Indian Pharmaceu cal Associa on, we won the bid in 2013. And the most adventurous journey of my life began... During the planning years, my team and I a ended two World Congresses and one regional congress. Our fun-tas c experiences at these events catalysed our planning to an enormous level. I believe that IPSF and all its Congresses are an amalgama on of meless friendships, undying unity and immense faith in it's principles that originate from building an innova ve future for career aspirants in pharmacy across the world, regardless of their cultural or educa onal background, and these con nue to inspire us even to this day. I had the good fortune of working with my remarkable Execu ve Commi ee and the Recep on Commi ee, a perfect combina on of power with responsibility; a team that accomplished hours of me culous planning and intense implementa on. I strongly believe that team work is paramount to organizing this event of such magnificence. The Team of IPSF WC 2015 has proved it beyond belief. A special men on and big thank you to the Indian Pharmaceu cal Associa on (IPA) , the organiza on without which we couldn’t have accomplished this herculean task.Their encouragement and unending support in all forms kept the ball rolling. Dr. T.V Narayana- our excellent mentor and Dr. Rao Vadlamudi- our dear IPA President (who were as strong headed as ever, yet role-played as our team members always) - seamlessly found a way out of any hurdle. Dr. T.B Nair- who at the age of 70 worked enthusias cally and effortlessly, always showed us the posi ve side to everything and paved our way through the past year! Mr. T. Jaypal Reddy, Dr. Surendra Manek, Mr. Kaushik Desai, Dr.Subodh Priolkar and Dr. Divakar Goli- our super able IPA Core team- pumped us up through thick and thin! It's because of all of them and my RC that every breakdown became a breakthrough- and we have come to realise our biggest crea on- The 61st IPSF World Congress, 2015 It's now me for us to create history that would go down a very long me in the future. We are all set to flag off this grand event and we are as excited as you readers are, to be finally availing this Congress booklet to you. Every page of this booklet unfolds each day of the Congress to the minutest detail ensuring you have a wonderful me at the Congress. 11
With this as my invita on, I look forward to seeing all of you in the pearl-city, Hyderabad, India at IPSF-WC, 2015 where we Un l then, HAPPY READING! To IPSF-WC,2015…IPSF-WC,2015…VIVA LA PHARMACIE!
Neha Dembla Chairperson, 61st IPSF World Congress, India
12
Messages
Rao V. S. V. Vadlamudi, Ph. D., President, Indian Pharmaceu cal Associa on (IPA) E-Mail: raovsvv@ipapharma.org, rao.vadlamudi@gmail.com
Gree ngs from the Indian Pharmaceu cal Associa on (IPA)! It is indeed a ma er of immense pleasure and great pride for me and the IPA to realise that our student body, the IPA -Students' Forum (IPA -SF), in a short period of 8 years since incep on has made giant strides, ďŹ rstly by bagging the pres gious Sidney J. Ralph award of the Interna onal Pharmaceu cal Students' Federa on (IPSF) for being the best student forum and secondly by taking the bold step to organise the 61st IPSF World Congress 2015 in India in Hyderabad in July-Aug 2015. The IPSF World Congress, the biggest event of the IPSF is organized by each member associa on every year. The World Congress is a 10 -day event, which serves as a great opportunity for students from 85 countries to "Connect-Catalyse-Innovate" to usher a bright future for both pharmacy prac ce and pharmacy educa on locally and globally. For IPA it is a proud moment to support the IPA - SF recep on commi ee and to witness them organising the 61st IPSF World Congress 2015 successfully. I feel extremely privileged to be a part of the "The 61st IPSF WC 2015" and wish the World Congress huge success!!
Rao V. S. V. Vadlamudi, Ph. D. Hyderabad. July 1, 2015
13
THE INDIAN PHARMACEUTICAL ASSOCIATION (EDUCATION DIVISION) Office at: S.B.D.College of Pharmacy. I Cross, Hanumanthanagar, Bangalore -19. Email:tvnarayana2000@yahoo.com
Dr. T.V.Narayana
Message It gives me an immense pleasure to know that the 61st IPSF world congress is being organized by IPA-Students Forum and IPSF at Hyderabad, Hotel Marriot Convec on Centre from 30th July to 9th of August 2015. Pharmacy educa on is key element to the changing des of the young pharmacy work force. There have been considerable efforts expended in India to keep up the unprecedental changes in pharma educa on as a whole. IPA educa on division as a mentor of IPASF is con nuously striving and guiding the pharmacy students to play a major role in the field of pharmacy. I wish the 2day scien fic and educa on symposium during the congress will give an insight to both aspiring and young professionals and will provide an excellent opportunity to the delegates to exchange view as on emerging tread on pharmacy educa on and science. I appreciate the efforts and hard work of the students in releasing the congress chronicle and extend my hear est gree ngs and wishes to the organizers.
Dr. T.V.Narayana Vice-President – IPA and Chairman, IPA-Education Division 14
MESSAGE
Hyderabad, the city of rich cultural heritage is the venue of 61 st International Pharmaceutical Students’ Federation – World Congress 2015 organized by Students’ Forum, the Student Chapter of Indian Pharmaceutical Association (IPA). The theme encompassing “API to Formulation – Process, Quality and Economics” is aptly cho sen considering the position India enjoys globally as a manufacturing hub. On behalf of IPA, I warmly welcome all the participants who have travelled from all over the globe. The credit of putting together an excellent program goes to the committed student members ably supported by IPA leadership team and mentored by Education Division of IPA. I wish you all a pleasant stay and an enjoyable and enriching experience with constructive exchange of ideas through meaningful interactions and scientific deliberations.
Kaushik Desai Hon. Gen. Secretary
15
Dear Future Pharmacists and Pharmaceutical Scientists, I would like to commend you for taking part in the biggest annual gathering of Pharmaceutical students in the world. The theme of this congress, “Encompassing API to Formulation — Process, Quality & Economics”, highlights the valuable knowledge that pharmacists and pharmaceutical Scientists bring to the discovery and development of medicines. The International Pharmaceutical Federation (FIP) believes that molecules become medicines only through the addition of pharmaceutical expertise. As future pharmacists, your mission will be to optimise the effects of these medicines through ensuring responsible use. Remember always, that patients are our priority and that medicine is a tool to achieve well-being. By being in Hyderabad, you are demonstrating four key qualities. The first is a wish to Connect with others, exchange ideas and tackle challenges together. The second is an Eagerness to learn, not only about pharmacy but about different cultures. The third is a Passion for pharmacy and, moreover, for the future of our profession. The final quality is an interest in international pharmacy. This is an excellent interest to have during your studies or early in your careers; globalisation in healthcare is growing in Significance. FIP is recognised as the leader of pharmacy at a global level. I hope your Interest continues as your careers progress and that you later become part of FIP. May the discussions you have at this 10-day IPSF event lead to many future achievements.
Dr Carmen Peña President International Pharmaceutical Federation (FIP)
16
Association of Pharmaceutical Teachers of India No.620 D, 35th Cross, 2nd Block, Rajajinagar, Bengaluru-560 010, INDIA 080 – 23325094 http://www.aptiindia.org
“Committed for Quality Pharmacy Education”
MESSAGE
1/7/2015
APTI is very much delighted to know that Indian Pharmaceutical Association through its IPA Students’ Forum is organizing first time in India IPSF World Congress 2015 at Hyderabad India. APTI welcome Pharmacy Students from 60 countries to India. Pharmacy Profession is a novel profession to serve the humanity. Super mighty has given us this golden opportunity to contribute as Pharmacist to save life, nurture life ,protect life and extend life by working as Pharmacist in different segments of Pharma cy Profession .To become successful in Pharmacy Profession love your profession, be passionate about your profession, think Positive and do tremendous hard work with discipline. You give the Pharmacy World best you have and best will come back to you. Let’s work together to bring solutions to make world happy and healthy and provide the best health care service so that society can remember the Pharmacist and Pharmacy Profession as No.1 profession . Finally God gave us two gifts; one is choice and second is chance------the choice of a good life and chance to make it the best life. If you came to Pharmacy Profession as your first choice, serving this profession your life will be very good. Even if you came to this profession by chance you can still make your life the best one by serving the people and making them happy. All the best for your life time careers in Pharmacy Profession.
Dr. Mahesh D. Burande President mahesh.burande@gmail.com Mobile: +919822016759
17
Dear Students, I congratulate you on hosting 61st Interna onal Pharmaceu cal Students' Federa on (IPSF) – World Congress 2015 in Hyderabad, India star ng from July 31, 2015. It gives me great pride and sa sfac on as IPA member that in such short me, you have accomplished a might task. Personally, it had added dimension of achievement as I was the one who ini ated IPA SF ac vity in Maharashtra State as President of IPA- MSB. The objec ve was to involve students in professional ac vi es at early age to create a young genera on of Members for IPA and to create a sense of belonging in students towards IPA. As President of IPA, I was involved in planning IPA SF at na onal level and my successor, Dr. Suresh formalised it into sub division of Educa on division of IPA. It is heartening to see it blossoming it to global level. I have seen hard work done by team to get this event to India and have full confidence in the team that the event will be a great success. All the best and keep India flag flying high, Regards,
Subodh Priolkar M.D. Colorcon
18
Message It gives me extreme pleasure to know that the 61st International Pharmaceutical Students' Federation World Congress (IPSF - WC) 2015 is being organised by Indian Pharmaceutical th th Association - Students Forum (IPA-SF) from 30 July to 8 August 2015 at Marriott Convention Centre, Hyderabad with the Theme Encompassing API to Formulation-Process, Quality & Economics. The delegates participating in the congress will share their rich experience and expertise on issues relating to the theme and global research in the ďŹ eld of the Pharmacy. The congress will surely be a platform and will provide an opportunity for the budding pharmacists to express themselves towards research and development. I hope the deliberations on the theme of the conference will ďŹ nd out solutions for ensuring quality pharmacy education and research in global level. I congratulate Local Organizing Committee of IPASF-WC 2015 and extend my best wishes, warm greetings and felicitations to the participants for the grand success of the World Congress.
President Indian Association of Colleges of Pharmacy
19
st
It is ma er of immense pride that 1 IPSF World Congress is being organized by IPA Students' Forum th th at Marriot Convec on Centre on 30 July to 9 of August. I wish the delivera ons of Scien fic and Technical sec ons during the congress would offer healthy pla orm to the students to apprise themselves with latest technological advancements in the field of Pharmacy. On Behalf of AIDCOC I congorulate IPA- Students' Forum for organizing such a mega event for the first me in India. I extend my best wishes to the congress.
Ravi Uday Bhaskar Secretary General AIDCOC
20
Venue and Accommoda on: The main venue for the event is Marrio Hotel and Conven on Centre. Par cipants will be accommodated in Marrio hotel. Rooms will be allo ed to the delegates on arrival. Room Deposit of €50/delegate will be collected by hotel staff. Address: Hyderabad Marrio Hotel and Conven on Centre, Opposite Hussain Sagar Lake, Tank Bund Road, Hyderabad – 500080
21
ARE YOU HUNGRY? All the meals except (lunch on 3rd August and dinner on 5thAugust would be served at a separate venue) will be served at Marrio Hotel. No lunch will be provided on July 30, 2015. No dinner will be provided during the free night on 3rd August. General mings (please refer to the app for specific changes in meal mings): Breakfast: 6:30 am to 8:30 am 1st Tea Break Lunch: 12:30 pm to 1:30 pm 2nd Tea Break Dinner: 7:00 pm to 8:30 pm
INFORMATION DESKS: A 24 hrs informa on desk will be placed outside the conven on area of Marrio hotel. Our volunteer will always be there to answer your ques ons round the clock. However feel free to contact any member of the team. Contact details are provided in the following sec ons.
Smoking and An - Drug policy: IPSF has a strict an - drug policy which will be no different in this Congress. People who wish to smoke can walk down to the smokers zone (lobby level and 2nd Floor). Alcohol consump on is strictly prohibited for the ages below 21. Anyone found with any drugs would be handed over to the police by the Marrio personnel and neither IPA-SF, IPSF nor Marrio would be responsible for the release of the student.
Other informa on/ Key notes: ¡ An amount of €50 should be deposited upon check-in into the hotel which will be
refunded a er check out. (Provided the list of items as men oned in the room deposit policy remain undamaged at the me of check out). ¡ An iden ty card should be worn during every event ll the end of the Congress for
iden fica on purpose. Without the iden ty card delegate will not be allowed to a end any session/ party. If the card is lost a fine of €5 will be charged.
22
¡ Registra on for the workshops should be done through the online forms which will be
shared by the RC. ¡ Transporta on for all the official events throughout the Congress will be provided by
the RC. ¡ Please maintain decorum and follow schedule mings as guided by the RC and Ex-Co
since together we will be responsible for the smooth running of the event. ¡ Any changes in the schedule will be brought to your no ce at the informa on desk
and also will be communicated through the app and daily newsle ers – so stay updated at all mes!
Congress a endance system : The recep on commi ee and IPSF have designed an a endance system in which a endance will be measured by the stamp cards which will be distributed at the beginning of the Congress and has to be kept safe when lost a fine of 5 € should be paid to get a new card. In order to receive the 61st IPSF world Congress cer ficate the a endance criteria is as follows: 100% of all educa onal and scien fic symposia sessions. ¢ 50% of the other workshops and events. ¢ This should collec ve make a minimum of 75% of total a endance. ¢ The par cipants coming for the first me should a end the “discover IPSF” session. ¢
Emergencies: A doctor will be available throughout the Congress for an medical assistance ¢ The general emergency phone number for police in India is 100. ¢ In case any emergency alarm is heard please stay calm and listen to the orders of RC or the professional emergency services. ¢
23
Desi Transla ons English Hello Thank You Please I`m sorry My Name is How are you what is your name where are you going? You we They Yes No What is that? How much does it cost? What time is it? where is it? free Open Close Right Left I don’t understand a bit! I understand just a bit! you speak too fast! a bit I don’t know, I can only speak english!
Hindi Namaste Dhanyawad Kripaya maaf kijiye mera naam kaise ho? aap ka naam kya hai kaha jaa rahe ho? aap hum voh haan nahi voh kya hai? kitne ka hai? time kya hua hai? kaha hai? muffth khula band baaya daaya mujhe kuch samajh nai aaraha! mujhe thoda samaj raha hai aap bahuth tez baat kar rahe ho thoda mujha samaj nahi aaraha!
Telugu Namaste Dhanyawadalu Dayachesi kshaminchandi na peru ela unaru? mi peru aenti ekada potunaru meru memu vaalu avunu kadhu ade aenti? ade aennta? time aenta? aekada undi? uchitamu tersi musasi kudi yedama Naku ardam avatledhu! naku koncham ardam ayetundi miru chala twaraga matladtunaru koncham naku ardam avatla, I understand english only!
24
Daily Schedule 0
July
July 7:00 - 9:00
31
About IPSF
15:30 - 17:00
Day 1
2015
CP meeting SEO meeting Opening Ceremony
9:00 - 12:00 IPSF in your corner
13:00 - 15:00
Day 0
30 2015 Arrivals, check-in, welcome party
All day
Model United Nations: Introduction
August
FIP + YPG
IPSF Pharmacy Profession Public Health: Communicating in Dr. H.D.R Vincent Jannin Awareness Campaign the Digital Age
Dr. Nabil Joseph Farah
1 2015 Educational Symposium "Bridging Gaps in Current Pharmacy Education"
Day 2
GA
9:00 - 9:45
Dr. B. Suresh
Pharmacy Education - Renaissance
9:45 - 10:30
Dr. Chandra Shekar
US pharmacist in 2015 – highly trained professionals, fighting for recognition as health care provider, one state at a time
10:50 - 11:35
Prof. C. K. Kokate
Pharmacy Education: Uniformity in course content
11:35 - 12:20
Dr. Srinivas Pentyala
Role Model in Science: Teacher, Advisor, Mentor and a Friend
13:40 - 14:25
Prof. Ralph J Altiere
14:25 - 15:10
Mr.T. K Ravi
15:30 - 16:15
Mr.T. JayaPal Reddy
16:15 - 17:00
Dr. T. V. Narayana
Entrusting Students to be Agents of Change Advanced learning and practice - Creating global standards Empowering the Future Enterpreneur to global leadership QA of pharmacy education. Role of stake holders.
Day 3 August 2 2015 Scientific Symposium "Catalyzing Innovation in Manufacturing and Delivery of Pharmaceutical Products" 9:00 - 9:45
Mr. Subodh Priolkar
Key-note address
9:45 - 10:30
Dr. Purnanand Sarma
Innovation and Entrepreneurship together Paving way for New Therapies with Better Outcomes
10:50 - 11:35
Dr. Krishna Ella
Innovation & Vaccine Hub of the World
11:35 - 12:20
Dr. Madhu Pudipeddi
Can India Sustain its Position as a Global Generics Provider
13:40 - 14:25
Dr. Akash Mathur
Business Potential of Innovative Pharmaceutical Services vis a vis Pharmaceutical Products
14:25 - 15:10
Mr. Anirudh Gautam
Role of Innovation in Generic Product Development
15:30 - 16:15 16:15 - 17:00
Mr. Manni Kantipudi Dr. Mahesh Bhalgat
Leveraging Innovation to offer Cutting Edge Pharmaceutical Research Solutions to Global Industry Opportunities and Challenges in Biotechnology-based products and the Role India can Play
August
9:00 - 10:30 11:00 - 12:30 13:30 - 15:00
15:30 - 17:00
3
Day 5 August 4 2015 IPSF Clinical Skills Event Saree Draping-Exclusively Attitude to Altitude in Pharmacy Increasing the Introductory Workshop for Girls Profession Employability Quotient IPSF Patient Counseling Event - Turban Draping- Preferably Attitude to Altitude in Pharmacy Effective Documentation Introductory Workshop for Boys Prrofession Continous Manufacturing, IPSF Compounding Event Student Exchange OfficerEPSA-IPSF Workshop “Granulation”: An overview Introductory Workshop Workshop Pharmacy at Your Fingertips – Using Technology to Strengthen Your Therapy Decisions
IPSF 7 Minutes to Inspire
AMR: Clinical Skills & Awareness
5
2015
August 9:00 - 10:30 11:00 - 12:30 13:30 - 15:00 15:30 - 17:00
Day 4
2015 Excursion RAs
GA
"Pharmaceutical R&D: New frontiers of innovation"
Day 6
Industrial visit GA PHC Preparations
25
August
9:00 - 10:30
11:00 - 12:30
6 Public Health: Communicating in the IPSF Clinical Skills Event - Team Digital Age Competition IPSF Clinical Skills Event Case Presentation Competition
13:30 - 15:00 IPSF Patient Counselling Event Beginner Preliminaries
IPSF Patient Counselling Event - Advanced Preliminaries
15:30 - 17:00
August 9:00 - 10:30
Gattefosse
11:00 - 12:30
Role of IPC in defining and maintaining quality standards of Medicines
Project Management Present needs of the Indian Pharma Industry from Academia The 3rd IPSF Young Researchers’ Forum I - World Café Discussion on Pharmacy Students Involvement in Research Projects The Great New Challenges facing the Pharmacists Worldwide in the New Millennium
7 2015 The National Health TRIPS and Post 2015: Service in the UK: The Opportunities to improve access Cost of Care and Future of to medicine Hospital Pharmacy Root Cause Analysis and CAPA system
Improving Patient Compliance by Formulation Design
13:30 - 15:00
IPSF Clinical Skills Event Individual Advanced
Model UNESCO
IPSF Clinical Skills Event Individual Beginners
15:30 - 17:00
Pharmacy Education Summit: Being the Ambassador for Change!
Model WHO
IPSF Training Opportunities
9:00 - 10:30
11:00 - 12:30
13:30 - 15:00
15:30 - 17:00
Day 7
2015 -
PHC Group 1 -
RC Workshop - Reserved PHC Group 2 -
Day 8 Conflict Resolution in Workplace relationships Packaging Validation: A critical need to ensure valid product Pharmacovigilence: An eye for detail in ADR Management Quality Risk Management in Pharma Industry
GA Compounding event (from 13:00)
Day 9 8 2015 Pharmacokinetics and its IPSF Patient Counselling Event - How to Run an Innovative applications Finals Public Health Career opportunities in Engaging Pharmacy Students in Regulatory Affairs utilizing IPSF Clinical Skills EventHow to Run an Innovative Public Health Activities knowledge of Regulatory Jeopardy Public Health Sciences Herbal formulation industry in Mrs. Archana Mugdhal workshop Challenges of Membership GMP - Recent Trends and India: Challenges and - Waiting for confirmation Promotion developments opportunities Pharma Research: IndustryStrategies for writing Academia-Regulatory Concern, Research Methodologies Pediatric Pharmacy research paper case Studies August Good practices in pharmaceutical industry
GA
26
Day 0 0
July
Day 0
30 2015 Arrivals, check-in, welcome party
All day
ARRIVALS AND CHECK – IN All the participants are requested to sign up at the registration desk upon arrival. Room keys and Kitbags will be provided to every delegate after financial and registration clearance at the desk. You will be guided at every step along the way. WELCOME PARTY The Reception Committee will warmly welcome the delegates and IPSF Ex-co at this party. The party will include Flag- Ceremony where each IPSF Full Member will get the flag of the country they are representing. The party will also have a lot of icebreakers, lightening the environment and making it conducive for interactions for IPSFers participating at 61st IPSF World Congress.
Day 1 July 7:00 - 9:00
31
About IPSF
9:00 - 12:00 13:00 - 15:00 15:30 - 17:00
IPSF in your corner Model United Nations: Introduction
Day 1
2015
CP meeting SEO meeting Opening Ceremony FIP + YPG
IPSF Pharmacy Profession Public Health: Communicating in Dr. H.D.R Vincent Jannin Awareness Campaign the Digital Age
Dr. Nabil Joseph Farah
GA
ABOUT IPSF Venue: Amber Hall Speaker: IPSF Execu ve Commi ee This workshop will introduce newbies to the IPSF Universe and enhance the knowledge of experienced members. Join the workshop and get energized for the upcoming days. CP MEETING Venue: Topaz Hall Speaker: IPSF Execu ve Commi ee Contact Persons from all associa ons meet to discuss the past year and needs for the future. SEO MEETING Venue: Opal Hall Speaker: IPSF Execu ve Commi ee Student Exchange Officers (SEO) from all associa ons gathers to discuss the past year and needs for the future. OPENING CEREMONY Venue: Marrio Conven on Centre The opening ceremony would be a formal ceremony on the first morning of the World Congress which would be inaugurated by Sri. K. T. Rama Rao, the Honarable Minister of Raj Panchayat and Informa on Technology, Government of Telangana. DRESS CODE: pick the most formal ou it from your wardrobe.(SHOULD BE BELOW KNEE LENGTH, AS GOVERNMENT PEOPLE ARE EXPECTED AT THE OCCATION ) 27
IPSF IN YOUR CORNER Venue: Pearl Garden, Halls – Topaz, Opal, Amber Some Fun me in groups at various corner of the venue. FIP + YPG Venue: Emrald Hall For young budding pharmacists to be introduced into the pharma world on a pla orm like IPSF WC MODEL UNITED NATIONS: INTRODUCTION Venue: Topaz Hall Speaker: Ms. Barbara Villela, IPSF Chairperson of Public Health MANCE POWERED BY MICRO NANO SYSTEMS USING S. E. L. F. Venue: Turquis Hall
IPSF PHARMACY PROFESSION AWARENESS CAMPAIGN Venue: Amber Hall Speaker: Ms. Stephenie Miler, IPSF Chaireprson of Professional Development Learn how to promote your profession and create a difference in the healthcare industry. PUBLIC HEALTH: COMMUNICATING IN THE DIGITAL AGE Venue: Diamond Hall Speaker: Mrs. Nirma Khatri Vadlamudi "According to an Ins tute of Medicine (2004) report, low health literacy nega vely affects the treatment outcome and safety of care delivery. Several studies reveal that up to half of pa ents cannot understand basic healthcare informa on. The mismatch between a clinician's level of communica on and a pa ent's ability to understand can lead to medica on errors and adverse medical outcomes. The lack of health literacy affects all segments of the popula on, although it is dispropor onate in certain demographic groups, such as the elderly, ethnic minori es, recent immigrants and persons with low general literacy. Pharmacist plays a key role in bridging the gap of lack of health literacy skills among pa ents and improper communica on with clinicians through health communica on. In this Public Health Communica on workshop, the instructor takes the par cipants through various behavior change theories, health message framing strategies, communica on styles to effec vely develop public health message for Direct Pa ent Care, Counseling or Public Health campaigns. Par cipants will get hands-on experience by working on real case studies".
28
WORKSHOP BY GATTEFOSSE Venue: Coral hall Speaker: Dr. H. D. R. Vincent Jannin PHARAMCEUTICAL PERFORPERFORMANCE POWERED BY MICRO NANO SYSTEMS USING S. E. L. F. Venue: Turquoise Hall
29
Day 2 Schedule (August 1) August
1 2015 Educational Symposium "Bridging Gaps in Current Pharmacy Education"
Day 2
9:00 - 9:45
Dr. B. Suresh
Pharmacy Education - Renaissance
9:45 - 10:30
Dr. Chandra Shekar
US pharmacist in 2015 – highly trained professionals, fighting for recognition as health care provider, one state at a time
10:50 - 11:35
Prof. C. K. Kokate
Pharmacy Education: Uniformity in course content
11:35 - 12:20
Dr. Srinivas Pentyala
Role Model in Science: Teacher, Advisor, Mentor and a Friend
13:40 - 14:25
Prof. Ralph J Altiere
14:25 - 15:10
Mr.T. K Ravi
15:30 - 16:15
Mr.T. JayaPal Reddy
16:15 - 17:00
Dr. T. V. Narayana
Entrusting Students to be Agents of Change Advanced learning and practice - Creating global standards Empowering the Future Enterpreneur to global leadership QA of pharmacy education. Role of stake holders.
Pharmacy Educa on – Renaissance Dr. B.Suresh, Vice-Chancellor, JSS University, Mysore & of Pharmacy Council of India, New Delhi Prof Bhojraj Suresh, M.Pharm., Ph.D., Vice-Chancellor, JSS University, for the past thirty years has been ac vely involved in upli ing the standards of pharmacy educa on and profession in India. He was elected in 2003 as the President of Pharmacy Council of India, the statutory body regula ng the pharmacy educa on and profession in India. He was once again reelected as the President of Pharmacy Council of India in August 2008 and August 2013 and has the unique honor being elected thrice to this leadership posi on. He is also the Chairman of the Scien fic Body of Indian Pharmacopoeia Commission, which is responsible for se ng of standards for pharmaceu cal substances and formula ons. Dr. Suresh is also the delegate member of the United States Pharmacopeia Conven on and also the member of the Council of Conven on of the USP. He has been invited to be the member of ACPE Interna onal Services Program Advisory Group, USA and is the Execu ve Member of CPA. He was also the past President of Asian Associa on of Schools of Pharmacy and Chairman of the Educa on Sec on of the Federa on of Asian Pharmaceu cal Associa on. He had pioneered the cause of promo ng “Pharmacy Prac ce” concept in India and has the unique honour of having introduced postgraduate programme in “Pharmacy Prac ce” and “Pharm D” programmes in India and con nues to strive to upli this facet of pharmacy profession by closely working with other global leaders. Dr Suresh has to his credit several na onal and Interna onal publica ons and has ini ated several interna onal collabora ons through bilateral, academic and research exchange programmes. He has to his credit of having organized several na onal and interna onal mee ngs and conferences in India and elsewhere, and had spearheaded the organizing of the World Congress of Pharmaceu cal Sciences 2011, 71st Interna onal Congress of FIP. He has ac vely involved himself with the educa on ini a ves of FIP and been an ac ve member of FIP Pharmacy Educa on Task Force. In recogni on of his invaluable services in the field of pharmaceu cal educa on, he is a recipient of several na onal and interna onal awards. 30
In recogni on of his invaluable services in the field of pharmaceu cal educa on, he is a recipient of several na onal and interna onal awards and to men on in par cular the FAPA Ishidate Award–2004 (Interna onal Award) and Doctor of Science (D.Sc.,) Honoris Causa conferred by The Tamilnadu Dr MGR Medical University, Chennai in 2007 and by the Rani Durgavathi Vishwavidyalaya , Jabalpur, Madhya Pradesh in 2012.Dr B.Suresh is also the recipient of the presi gious ' Eminent Pharmacist Award' of the Indian Pharmaceu cal associa on , the 'ML Shroff award' of the Indian Hospital Pharmacists Associa on and the 'KC Cha erjee award' of the Indian Pharmacy Graduates Associa on. Dr.B Suresh is also the 'Interna onal Commissioner' of Accredita on council for Pharmacy Educa on, (ACPE) USA. He con nues to provide his leadership role in his mul faceted career by serving on several na onal and Interna onal statutory commi ees, viz. Drug Technical Advisory Board, Na onal Board of Accredita on, na onal commi ee for Clinical establishments and commi ee for Control and Supervision of Experiments on Animals (CPSEA). He is fondly liked by all his colleagues for his humane approach and his excellent team leadership. Abstract: Pharmacy educa on in India has undergone a paradigm shi in the last two decades. More than 1500 Pharmacy ins tu ons in India cater to the varying needs of the profession at different levels. Un l li le more than a decade the pharmacy graduates were involved mostly in manufacturing of medicines and the tradi onal dispensing of medicines and pa ent care services were supported though pharmacists who had a two year diploma in pharmacy qualifica on. Although, this resulted in tremendous growth and innova on in Pharma Industry leading to India as a global Pharma des na on, it failed to gain societal recogni on for the pharmacy profession. The concept of pa ent-oriented pharmacy prac ce was first introduced in India in the year1995, by the introduc on of prac ce-based and pa ent-focused postgraduate course, Master of Pharmacy in Pharmacy Prac ce. However, a Renaissance in Pharmacy educa on took place only a er the introduc on of the prac ce-based, six years, 'Doctor of Pharmacy (PharmD)' degree course by the Pharmacy Council of India in the year 2008. This mul -faceted course has redefined the role of pharmacists in the Indian healthcare system. There has been a paradigm shi resul ng in the (i) increased number of students-pharmacists working in the wards of hundreds of hospitals and (ii) increased pharmacists' capabili es in providing pa ent care services. The future of the pharmacy profession lies on (i) developing well-qualified, knowledgeable, skilled and competent human resources (ii) providing high quality pharmaceu cal care services in healthcare system and (iii) fulfilling the other professional obliga on/responsibili es based on the societal need. These could only be achieved through change in the legisla ve framework in order to improve and maintain high standards of pharmacy profession both educa onal as well as prac ce se ngs.
31
US pharmacist in 2015 – highly trained professionals, figh ng for recogni on as health care provider, one state at a me. Dr. M. Chandra Sekar M. Chandra Sekar did his B.Pharmacy (1974), M. Pharmacy (1976), Birla Ins tute of Technology and Science, Pilani, India. His M. S. (1980), Ph.D. in Molecular Pharmacology (1984), University of Bri sh Columbia, Vancouver, Canada and Post Doctoral training (1984 - 1987), University of Wisconsin, Madison, U.S.A. M. Chandra Sekar was working as professor of Pharmaceu cal Sciences from 2013, University of Findlay, Findlay, Ohio. He worked as the Associate Professor Pharmaceu cal Sciences (2007 – 2013) in University of Findlay, Findlay, Ohio and Adjunct Professor (2010 – Present) in JSS University, Mysore, India and Pharmacist- PRN (2007 - 2010) in University of Cincinna Hospital, Cincinna , Ohio and Pharmacist (2000 – 2007) in University of Cincinna Hospital, Cincinna , Ohio and Pharmacist (1999 – 2000) in Bay Medical Center, Panama City, Florida, Research Assistant Professor (1988 -1999), School of Medicine, Departments of Pathology and Pharmacology in University of Alabama at Birmingham, Birmingham, Alabama and Associate Scien st (1991 - 1999) in Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama. He was the Invited speaker CIMS-CON 2012, Associate Editor, Journal of Pharmaceu cal Sciences and Pharmacology (2013 to present) and a ained many other awards and recogni ons. He has membership in organisa ons like American Associa on for Advancement of Science,American Society of Biochemistry and Molecular Biology,American Society of Pharmacology and Experimental Therapeu cs,American Pharmacist Associa on,Ohio Pharmacist Associa on, ASIOA – life member. He was licenced in Ohio Pharmacist License – 07/00 and Florida Pharmacist License - 03/95 – 10/12. Abstract While the word “pharmacist” is used for pharmacy--educated professionals in many parts of the world, scope and expecta ons for what that professional is capable of doing varies widely. Few decades ago, even in US, pharmacist's responsibility only extended into filling doctor's prescrip on accurately. At that me, few mo vated students who went onto get addi onal training, were awarded Pharm D – and those graduates primarily staffed clinical posi ons at large hospitals or pursued research and teaching at universi es. Since 2002, US have shi ed to Pharm D degree as the basic requirement for entry into pharmacy profession. This has resulted in longer and more expensive training for students. While educa onal qualifica ons and training for gradua ng pharmacists has expanded drama cally over the last decade in US, the actual progress in professional prac ce experience have been more limited. Introduc on of “affordable care act” has s mulated the need for greater collabora on between various healthcare professionals to improve pa ent outcome. 32
In this presenta on, I will cover the major components of the current curriculum in US, how they are delivered and student's expecta ons and outcomes. Presenta on will also focus on major factors – both societal and healthcare related that is responsible for underu liza on of pharmacist exper se in US, and what prepara ons and groundwork need to be done before rolling out Pharm D program in developing countries that really has an impact on the public health outcome for that country.
Pharmacy Educa on: Uniformity in course content Prof. (Dr.) Chandrakant Kokate, Vice-Chancellor, KLE UNIVERSITY, BELAGAUM. Karnataka, INDIA. Prof. (Dr.) Chandrakant Kokate is the Present Pharmacy Board Chairman of NAAC. He was the Vice–Chancellor, Kaka ya University, Warangal, A.P. He was President, 50th Indian Pharmaceu cal Congress along with Federa on of Asian Pharmaceu cal Associa on (FAPA), Na onal President-Indian Pharmaceu cal Associa on, President-Indian Society of Pharmacognosy. Prof.C.K.Kokate is Chairman-Expert Panel Commi ee for approval of Fixed Dose Combina ons,(FDC's) Ministry of Health, Government of India. Chairman, Pharmacy Accredita on Commi ee of Na onal Board of Accredita on (NBA). His NATIONAL & INTERNATIONAL AWARDS AND FELLOWSHIPS including Eminent Pharmacist Award of Indian Pharmaceu cal Associa on, Prof.G.P.Shrivasta Award of Associa on of Pharmaceu cal Teachers of India, Prof.M.L.Schroff Award of Indian Hospital Pharmacists Associa on, Prof.M.L.Khorana Award of Indian Pharmaceu cal Associa on, Shri.K.C.Cha erjee Award of Indian Pharmacy Graduates Associa on, Shri.B.V.Patel Award of B.V.Patel Trust; and Life Time Achievement Awards of Associa on of Pharmaceu cal Teachers of India; Indian Society of Pharmacognosy; Indian Associa on of Pharmaceu cal Scien sts & Technologists and Interna onal Society of Ethnopharmacology (Indian Chapter). He guided 17 students for Ph.D programme and 40 students for PG in Pharmacy. He authored seven books in Pharmacognosy / Pharmacy. One book is in 50th Edi on. Around three lakhs copies have been sold, so far. He Published about 115 research papers in Na onal and Interna onal Journals. He Examined so far, 70 Ph.D. theses in Facul es of Medicine, Pharmacy, Science and Technology. He chaired 20 Scien fic sessions at Interna onal Conferences and around 50 Na onal Mee ngs. He presented 50 research papers at Interna onal Conferences and about 120 papers at Na onal Mee ngs. Abstract The landscape of pharmacy educa on across the globe has witnessed significant qualita ve and Quan ta ve transforma on since the beginning of 21st Century. Over past two decades, India has covered a long distance on the path of expanding the ins tu onal infrastructure for dissemina ng educa on in pharmaceu cal sciences. 33
The accredited pharmacy ins tu ons in different parts of the world are expected to be the epicenters of knowledge explosion by ac ng as nuclei for knowledge crea on, storage and dissemina on. In order to understand global trends in pharmaceu caI sciences, some degree of uniformity is expected in the course content of pharmacy, keeping in view the emerging areas of pharmacy prac ce and pharmaceu cal Technology. The accredited pharmacy ins tu ons in different parts of the world are expected to be the epicenters of knowledge explosion by ac ng as nuclei for knowledge crea on, storage and dissemina on. In order to understand global trends in pharmaceu caI sciences, some degree of uniformity is expected in the course content of pharmacy, keeping in view the emerging areas of pharmacy prac ce and pharmaceu cal Technology. In the context of globaliza on of professional educa on, it is expected that a pharmacy student migra ng from one country to the other is able to adopt to the changed ecosystem of educa on dissemina on with comfortable degree of sa sfac on.The need of the hour is ensure some degree of uniformity in academic program offered at the graduate level in pharmacy. At least, 75 percent of the course content in pharmaceu cal sciences should be uniformly covered, while remaining 25 percent could vary based on the local requirements and expecta ons. The advancements in the fields of drug development, manufacturing pharmacy, quality control and quality assurance, pharmaceu cal biotechnology and pharmacy prac ce are required to be understood by all the students of pharmacy across the globe. The curriculum of professional courses including pharmacy, offered in different countries is framed and approved by their respec ve Regulatory Bodies. It is desired that coordina ng Board at the global level be cons tuted and assigned the task of the dra ing common core syllabus for graduate program in pharmacy. This shall certainly facilitate free flow of knowledge seekers and knowledge disseminators across the globe which ul mately, shall lead to universiliza on and consolida on of the profession.
Role Model in Science: Teacher, Advisor, Mentor and a Friend Srinivas Pentyala, Director of Transla onal Research & Associate Professor, Department of Anesthesiology, Stony Brook Medical Center, Stony Brook, NY. His educa on includes MS (1986) Sri Venkateswara University Neurobiology Tirupa , India, PhD (1989) Sri Venkateswara University Neurotoxicology Tirupa , India and Post-Doctoral Fellow University of Mississippi Medical Signal Center, Jackson, MS Transduc on. His appointments includes From To Title Ins tu on & Loca on 2006 Present Director of Transla onal Research, Stony Brook Medical Center, Anesthesiology Stony Brook, NY, 2006 Present Clinical Associate Professor, Stony Brook Medical Center, Health Sciences Stony Brook, NY,2005 34
Present Adjunct Associate Professor, Dowling College, Biology Oakdale, NY, 2004 Present Adjunct Associate Professor, Adelphi University, Biology Garden City, NY and 2004 Present Adjunct Faculty, Urology, Stony Brook Medical Center and many more. His Research interests includes 1.Rapid Diagnos c methods2. G-proteins, PLC and Ca2+ signaling by Hormones, Anesthe cs, Toxicants and Drugs. 3. Bioac ve pep des - Lead drug compounds discovery. 4. Matrix degrading Proteinases: Role and regula on in cancer cells and Apoptosis. Abstract: Educa on is cri cal to the progress of humanity through its unveiling of the intricate processes that co-mingle in different aspects of life. Par cularly, the next genera on of ci zens will carry a burden of scien fic uncertain es that will require the breaking of new fron ers, discovery and inven on for the very survival of humanity. Discrimina on based on economic, social and racial status in the impar ng of scien fic knowledge, burdens society and slows the progression of scien fic knowledge. Despite these challenges and the preeminence of the field of pharmacy research, students con nue to lag behind, par cularly in transla ng scien fic knowledge into applica ons that are beneficial for mankind. The understanding of science beyond the textbook is not normally an aspect that is impressed upon young minds. This might be one of the strongest reasons why, students lose interest. Instead, they develop the no ons that science is difficult and that the payoffs are intangible. Science is not just reading a textbook, following the syllabus and ge ng high grades on an exam. Science is a process of measurement, observa on, and reasoning that could answer society's most pressing ques ons. If this idea is ins lled into the students at an early stage, then sufficient talent may be a racted to careers in the field of pharmaceu cal sciences. On the other hand, if barriers are erected to talented individuals, the discoveries and progress will be insufficient to meet our needs. It is the responsibility of “a role model” to show that science is “COOL” as well as “HOT”, so that students can get involved in science that makes sense. Taking examples from a career spanning 25 years, the impact of commi ed teaching, advising, mentoring, inspiring and exci ng students will be discussed, highligh ng several scien fic inven ons and discoveries in the process
Entrus ng Students to be Agents of Change Ralph J. Al ere, Professor and Dean of the University of Colorado Skaggs School of Pharmacy and Pharmaceu cal Sciences, USA Ralph J. Al ere is Professor and Dean of the University of Colorado Skaggs School of Pharmacy and Pharmaceu cal Sciences, USA. Professor Al ere's career in educa on and research spans nearly 35 years that includes several years in the pharmaceu cal industry and over 30 years in faculty posi ons at the University of Kentucky and the University of Colorado. Prior to taking on the role of associate dean for academic affairs, Dr. Al ere had a con nuously funded research program for more than 15 years. 35
As associate dean for academic affairs at the University of Colorado Skaggs School of Pharmacy, he was responsible for leading the conversion of the pharmacy educa on program from the BS to the Doctor of Pharmacy (PharmD) degree program and had administra ve oversight for development of a largely online non-tradi onal post-BS PharmD degree program. From 1998 to 2005, he was director of the Pharmacy Student Research Conference – Western Region. He served as a member of the advisory board for the UC Denver Center for Bioethics and Humani es and the Colorado Clinical Transla onal Sciences Ins tute. He has held numerous posi ons in the American Associa on of Colleges of Pharmacy (AACP) including Chair of the Sec on of Teachers of Biological Sciences and was a fellow in the inaugural AACP Leadership Fellows Program. He is the recipient, as co-author, of local and na onal innova ons in teaching awards, as well as the 2004 recipient of the University of Colorado Health Sciences Center Diversity Award and the University of Colorado Anschutz Medical Campus Chancellor's Diversity Recogni on Award in 2007. As a leader in diversity efforts, Dr. Al ere served as director of a HRSA Center of Excellence Diversity Program. In his role as dean, he has administra ve responsibility for a school na onally ranked number 4 in research funding and in the top 20 percent of all pharmacy schools in the US, na onally and interna onally recognized clinical pharmacy programs and innova ve interna onal pharmacy educa on programs. Professor Al ere also serves as President of the Interna onal Pharmaceu cal Federa on (FIP) Academic Pharmacy Sec on and a member of the FIPEd Internal Reference Group, the FIP Board of Pharmacy Prac ce, the FIP Congress Programme Commi ee and the FIP Academic Ins tu onal Membership Advisory Group. Abstract: As pharmacy educa on moves towards a more socially accountable and competency and performance based system, learning and assessment are expanding beyond the classroom and into the experien al prac ce based environment. The challenge and opportunity before us is how to prepare pharmacy students for a profession that is changing rapidly and that allows students to impact future direc ons of the profession. In some countries, medical educa on is mee ng this challenge by adop ng “Entrustable Professional Ac vi es” for students to perform. This workshop will begin by briefly describing the Entrustable Professional Ac vity process as a mechanism to create acceptance of students' par cipa on in the health care process and sharing examples of student ac vi es in innova ve experien al se ngs. The majority of me will be spent with students exploring models of par cipa on in innova ve prac ce and strategies for overcoming challenges in this environment. Learning outcomes Par cipants will: 1. Iden fy the role of experien al educa on in various countries 2. Use the Entrustable Professional Ac vi es model to gain acceptance of student par cipa on in the healthcare process 3. Determine challenges inherent in being a student in the health care environment and strategies for overcoming them.
36
Advanced learning and prac ce - Crea ng global standards Dr. T. K. Ravi Principal, College of Pharmacy, Sri Ramakrishna Ins tute of Paramedical Sciences, Sri Ramakrishna Hospital Campus, Coimbatore. PIN: 641044 Dr. T. K. Ravi is the Principal and Head, Department of Pharmaceu cal Analysis, College of Pharmacy, Sri Ramakrishna Ins tute of Paramedical Sciences, Coimbatore with 27 years of experience. He obtained his Bachelor's, Master's and Ph.D. degrees in Pharmacy from College of Pharmaceu cal Sciences, Manipal. In 27 years of his experience as a teacher and researcher he has to his credit, 41 interna onal and 104 na onal publica ons in peer reviewed journals. He has successfully guided 50 postgraduate thesis, 11 doctoral thesis (Ph. D.) and presently guiding 6 doctoral research scholars in the field of Pharmaceu cal Chemistry and Pharmaceu cal Analysis. He served as a member in several na onal and interna onal professional bodies, which include Inspector and Member, Pharmacy Council of India, New Delhi. He is also a nominated Member, Council to Regulate Clinical Establishments in India, New Delhi. He has been elected three mes as the Governing Council Member, President, Faculty of Pharmacy of The Tamil Nadu Dr. M.G.R. Medical University, Chennai. He is also one of the Board of Directors, Asian Associa on of Schools of Pharmacy, Malaysia (20082015). He was also the Board of Studies and Research Board Member of many Indian Universi es He is a recipient of several pres gious awards and fellowships which includes, “Dis nguished Alumni award” of College of Pharmaceu cal Sciences, Manipal, Karnataka; “Fellowship award of Associa on of Biotechnology and Pharmacy” during 2009, IPA Fellow award and “Professional Excellence Award” by the Tamil Nadu Dr. M.G. R. Medical University. At present he is the Convener, Scien fic Services Commi ee, and Indian Pharmaceu cal Congress Associa on for a period of three years (2013-2015). He also served as the Treasurer, Indian Pharmaceu cal Congress Associa on, Chairman, and Scien fic Services Commi ee (LOC) for 64th IPC at Chennai during 2012 and was the Scien fic Convener for the Indian Pharmaceu cal Associa on Conven on 2009 & 2010. He was the Chairman of the II Na onal Conven on of Pharmacy Educators held at Coimbatore (2006) and was the Organizing Secretary, 4th Na onal Conven on of Associa on of Pharmaceu cal Teachers of India (1999). He is the life member of many professional bodies like IPA, IPGA, and APTI. He is a reviewer for various journals like Indian Journal of Pharmaceu cal Sciences, Indian Journal of Pharmaceu cal Educa on, etc. He has also travelled widely and presented papers, delivered several invited lectures and chaired sessions in number of na onal and interna onal conferences. Abstract: Prac ce of Pharmacy has a rich history of advancing prac ce through innova on. These innova ons helped to mold Clinical prac ce into a pa ent-centered discipline recognized for its contribu ons to improve medica on therapy outcomes. The development of professional competency extends far beyond the mere acquisi on of knowledge. Lecture-oriented classes generally result in students being passive learners, with informa on memorized in the short term for an examina on but forgo en a erwards . 37
Lectures provide li le opportunity for students to engage in thinking or problem-solving ac vi es, and are limited in their ability to elicit traits of professionalism. Ac ve-learning strategies will improve reten on of knowledge, thinking abili es, problem-solving, and foster development of professional traits. Effec ve performance of clinical ac vi es like medica on history interview, clinical problem solving, medical informa on evalua on, drug therapy monitoring, pa ent medica on counseling, Drug Informa on Services, ra onal medica on use, Adverse Drug Reac on Management, Assessment of Drug Interac ons etc., are the major skill sets defined for a professional Pharmacy prac ce educa on. Inquiry-based approaches may have par cular value in health professions educa on by allowing students to learn material in the process of applying it to solve actual pa ent care problems. However, most prac ce competencies are developed through a dynamic interplay between curricular components and prac cal applica on, and not solely developed in the experien al learning environment. The growth of academic–prac ce partnerships could improve this trend and s mulate innova on among the next genera on of pioneering prac cing professionals. Although collabora on facilitates innova on, academic ins tu ons and health care systems/organiza ons are not taking full advantage of this opportunity. The academic–prac ce partnership can be op mized by making both partners accountable for the desired outcomes of their collabora on, fostering symbio c rela onships that promote value added pharmacy prac ce services and emphasizing con nuous quality improvement in the delivery of these services. This further supports the idea that prac ce experiences should occur con nuously throughout the curriculum, not in discrete, isolated blocks. When evalua ng and designing prac ce models to achieve a preferred vision for pharmacy prac ce, it is instruc ve to examine the elements of pharmacy prac ce that are essen al to ensure op mal medica on use. In a fully integrated prac ce model, pharmacists should have dedicated service assignments. The direct involvement of a pharmacist throughout the medica on-use process has been shown to ensure con nuity of care, reduce mortality rates, and minimize the risks, decrease the costs, and improve the outcomes associated with drug therapy. The academic–prac ce partnership can foster innova on by providing effec ve leadership, adop ng new approaches to professional educa on and training. With appropriate leadership and support, a shi in current professional educa on, training prac ces, and a commitment to cul vate new and innovative practice advancements that will improve patient outcomes and maintain global standards in health care.
38
Empowering the Future Enterpreneur to global leadership Mr. Jayapal Reddy Thumma, Chairman of St.Peter's Group of Ins tu ons
Mr. Jayapal Reddy Thumma, a Master graduate in Business Administra on and the Chairman of St.Peter's Group of Ins tu ons. Presently his Ins tu ons promote St.Peter's Pharmacy, Four Schools in SSC, CBSE and Interna onal Schools apart from St.Peter's Engineering College. And also he is the Managing Director of Teach Global Services Pvt Ltd, Hyderabad. Presently he is the Core Commi ee Member of Indian Associa on of Colleges of Pharmacy (IACP) in addi on he is also the invitee member of the Execu ve Council of Indian Pharmaceu cal Associa on( I P A), Mumbai. Presently Execu ve Council Member of Indian Pharmaceu cal Congress Associa on ( I P C A). Took charge as President, General Secretary and Treasurer from 2001 to 2015 for Andhra Pradesh Pharmacy Colleges Associa on which has more than 300 colleges in its fold. Mr Reddy also took ac ve role in FIP World Congress 2011, Hyderabad in India Host Commi ee. In 2012 as a Chairman LOC, St.Peter's Inst of Pharmaceu cal Sciences, Warangal hosted IPA Student Congress which was the most successful events of IPA-SF and now Core Commi ee Member of Students World Congress IPSF 2015. Apart from this organised Module I, II and VI of IACP Advanced Learning Series for Pharmacy Prac ce & PharmD students. Also took ac ve part in CEC of 1st Indian Congress of Pharmacy Prac ce in 2014 at Bangalore by IACP. Apart from this organised more than 60 Na onal Seminars/ Symposiums in Pharmacy & Engineering. Delivered several Lectures on Business Mgmt and Key-Note addresses on Na onal pla orms. Presented papers at FIP, AASP & other world congress meets and travelled to United States, Egypt, China, Swiss, Turkey, Portugal, Singapore, Indonesia, Dubai, Thailand, France, Uzbekistan, Nepal , Italy, etc . Abstract: This is an era of opportuni es for the younger genera on empowered with certain skill sets at the global level. As we are all aware that A tude, Knowledge and Skills make an individual capable of working under any condi ons of his profession, we shall now focus our discussion to health care profession in all aspects. When we refer to the buzzword “Global Leadership”, an aspiring entrepreneur such as a young pharmacy student has many aspects to look into. It all starts with what kind of persona he or she has. The power of thinking is so enormous that it develops a person's ability to control the en re stream of business. It generates the long and un ring strategy of adop ng to understand economics from dreaming to delivering a product to the end user. The future global entrepreneur has to develop mul dimensional thinking encompassing different business models, virtual R & D, marke ng, various formats of supply chains and world taxa on systems ahead. As we observe that the tradi onal block buster models in terms of research, sales, dispensing and collabora ons will disappear very soon. Already me is witnessing a shi from fixed dosage combina ons to imaging, from imaging to ssue engineering to therapeu c monoclonals and nano pills to pharmacogenomics/biomarkers/gene-based therapies to nano carriers and very shortly to human cell therapies. 39
We even will be shi ing towards virtual process designs to valida ons. There will be new manufacturing technologies such as exible produc on, con nuous processing and automa on to transgenic produc ons. Even the health care market leadership of G7 na ons will be coming down, as E7 na ons will be growing at 300% against 40% of G7 na ons. So, if a current pharma graduate chooses to empower himself with predic ng the future trends of Global Pharma Markets, for sure he/she would be a front-runner to grab the Global leadership posi on as an Entrepreneur.
QA of pharmacy educa on. Role of stake holders. Dr.T.V.Narayana completed his B.Pharm,M.Pharm, PhD from Andhra University, India and having 28 years of experience in Teaching and Administra on at various capaci es of Pharmacy Educa on. Presently working as Director of Vikas Ins tute of Pharmaceu cal Sciences, Rajahmundry, AP. He is Mentor of the IPA Students Forum and with his guidance IPA SF achieved many honours and milestones including hos ng of the 61st IPSF world congress in India. He served as central council member of Pharmacy Council of India, New Delhi, a statutory body of Ministry of H&FW that regulates Pharmacy educa on in India and ac vely involved in various commi ees of PCI like Professional Pharmacy commi ee, Pharmacy Ethics and Educa on Regula ons Commi ee and Na onal Task Force for Quality Assurance of Pharmacy Educa on. Dr.T.V.Narayana is also holding several posi ons in various Pharmacy organiza ons represen ng Pharmacy Educa on. He is Vice President of The Indian Pharmaceu cal Associa on, Mumbai and Chairman of IPA Educa on Division for the fourth term, Hon Secretary of Pres gious Indian Pharmaceu cal Congress Associa on (IPCA), Director of Indian Associa on of colleges of Pharmacy, core commi ee member of World Pharmacy Congress held at Hyderabad in 2011 and Joint Secretary of the 63rd IPC Bangalore 2012, LOC secretary of 17th APTI Conven on in 2013, Hon Secretary of IPA Conven on in 2014, etc. He has received several awards to his credit including the Fellowship of IPA in 2005 and Fellowship of Associa on of Biotechnology and Pharmacy in 2007, Shikshak Bhushan award in the year 2008, BV Patel Trust Memorial Award in 1980 for securing 1st seat in Pharmacy. He has represented India in world Pharmacy congresses of FIP held at Bangkok in 2014, Amsterdam in 2012, Lisbon in 2010, Istanbul in 2009, and Beizing in 2008, as oďŹƒcial representa ve of IPA and par cipated in Academic Pharmacy sec on mee ngs and Global Pharma Educa on Task Force mee ngs. He has presented 28 oral and 78 posters at both Na onal and Interna onal conferences of FIP, FAPA, AASP, held at Amsterdam, Portugal, Turkey, Australia. Switzerland, China, Philappines, Japan, Egypt, South Korea, Thailand etc., He is on editorial boards of reputed journals like Pharma Times, Pharmabit, Pharmanext, and advisory board member of 5 Pharmacy Ins tutes. He has organized 6 Interna onal Conven ons, 12 Na onal workshops, 4 students' congresses, 95 seminars on career prospects in pharmacy at various places through out the country and par cipated in more than 100 conferences as resource person. Pharmaceu cal Industry. The changing scenario in societal requirement and more emphasis on 40
Abstract: The origin of pharmacy ins tu ons in India dates back to 1899 in Madras for training of pharmacists followed by the state medical faculty of Bengal in 1928. The first UG program in pharmacy was started at BHU in the year 1932 with curriculum based on syllabus of University of London. Later various Universi es in respec ve states started the Pharmacy ins tu ons impar ng Diploma, Undergraduate, Postgraduate and Doctoral programmes in Pharmacy. At present there are nearly 1100 ins tu ons offering various pharmacy programmes with an annual intake of nearly 60000 students. The Pharmacy Council of India (PCI) is a statutory body governed by the provisions of the Pharmacy Act 1948 passed by the Parliament regulates the Pharmacy educa on and profession in India, The syllabus is more industry oriented rather than Prac ce oriented and mainly focused to cater the needs of the health care system indicates a clear shi in the science based pharmacy educa on to prac ce based recently in India. As a major breakthrough in the history of Pharmacy educa on in India, the Pharm.D regula ons have been no fied in the Gaze e of India on 10th May, 2008 with an aim to equip the future pharmacist of India with skills of not only dispensing medicines but also to serve as counselor of medicines with focus towards pa ents and prescriber of drugs. At present nearly 150 ins tu ons are offering this programme throughout the country. As the programme is newly implemented, the PCI is organizing various training programs to the staff and students in associa on with various stake holders to ensure that assured quality of pharmacy educa on is maintained.
41
Day 3 (August 2) Day 3 August 2 2015 Scientific Symposium "Catalyzing Innovation in Manufacturing and Delivery of Pharmaceutical Products" 9:00 - 9:45
Mr. Subodh Priolkar
Key-note address
9:45 - 10:30
Dr. Purnanand Sarma
Innovation and Entrepreneurship together Paving way for New Therapies with Better Outcomes
10:50 - 11:35
Dr. Krishna Ella
Innovation & Vaccine Hub of the World
11:35 - 12:20
Dr. Madhu Pudipeddi
Can India Sustain its Position as a Global Generics Provider
13:40 - 14:25
Dr. Akash Mathur
Business Potential of Innovative Pharmaceutical Services vis a vis Pharmaceutical Products
14:25 - 15:10
Mr. Anirudh Gautam
Role of Innovation in Generic Product Development
15:30 - 16:15 16:15 - 17:00
Mr. Manni Kantipudi Dr. Mahesh Bhalgat
Leveraging Innovation to offer Cutting Edge Pharmaceutical Research Solutions to Global Industry Opportunities and Challenges in Biotechnology-based products and the Role India can Play
Subodh Priolkar is an MBA from NMIMS, Mumbai and B. Pharm. from Bombay College of Pharmacy, Mumbai. He has more than 30 years of experience in various mul -na onal pharmaceu cal companies. He was responsible for spearheading business opera ons of Aptar Pharma. He was elected in 2003 as the youngest ever President of IPA and was instrumental in various ac vi es in industry as well as in academia. He joined Colorcon in 2008 as Managing Director. As Regional managing director for Colorcon South Asia, he is responsible for the growth of business. His business acumen has led to the expansion and commissioning of the largest manufacturing facility of Colorcon in Goa, India.
Abstract: In a 2004 report, Innova on and Con nuous Improvement in Pharmaceu cal Manufacturing, US Food and Drug Administra on, 2004, the US FDA put the problem this way: “Pharmaceu cal manufacturing opera ons are inefficient and costly. Compared to other industrial sectors, the rate of introduc on of modern engineering process design principles, new measurement and control technologies, and knowledge management systems is low. Opportuni es for improving efficiency and quality assurance . . . are not generally well recognized.” Addi onally, pharmaceu cal industry is under tremendous pressure as many countries are cu ng their health care budget resul ng in reduced prices and reimbursement rates. This evolu on nega vely affects gross profits and sales volumes. Increased compe on takes place due to generic companies aggressively seeking to extend their market share. The R&D success rate of ethical pharmaceu cal companies is substan ally decreasing while patent protec on of block busters of the '90's is slowly but surely fading away. All these factors lead to declining company revenues while increased R&D budgets are required to keep up R&D success rates of the past. This requires each en ty of a company to dras cally increase its efficiency. Product Development will need to find ways to speed up development and transfer. The Supply Chain en ty as a result will need to reduce costs, improve produc on economics and increase manufacturing flexibility. This presenta on would highlight some of the advances in manufacturing of pharmaceu cal dosage forms that could help develop robust formula ons and increase the produc vity.
42
Innova on and Entrepreneurship together Paving way for New Therapies with Be er Outcomes Dr. Purnanand Sarma (a.k.a. Sarma Duddu) Dr. Purnanand Sarma (a.k.a. Sarma Duddu) serves as the President and Chief Execu ve Officer at TARIS Biomedical in Lexington, MA, USA. Dr. Sarma has more than 23 years of execu ve leadership experience in large Pharmaceu cal and Biotech Companies, across 3 con nents. Dr. Sarma has proven track record of building high energy teams and high value ventures. In his current role, he is aggressively building a high value specialty urology business at TARIS, based on technology licensed from MIT and backed by leading US venture capitalists. In August 2014, he sold one of TARIS' highly specialized products (LiRIS®) for the treatment of Inters al Cys s to Allergan in a deal worth nearly $600M. Prior to TARIS, he held mul ple execu ve posi ons, including General Manager and Vice President of Worldwide Drug Delivery Technologies at Cephalon Corpora on, USA and Vice President of Worldwide Pharmaceu cal Development and founding Managing Director of India Opera on at Nektar Therapeu cs, USA. Dr. Sarma started his career at SmithKline Beecham Pharmaceu cals, in product development. Author of numerous peer-reviewed ar cles, book chapters and patents, he is a frequent speaker at various technical and business forums. Dr. Sarma earned a Ph.D. in Pharmaceu cs from the University of Minnesota and a B. Pharm. from Andhra University, Visakhapatnam, India.
Abstract: Despite major investment in R&D, the innova on gap in the Pharmaceu cal industry con nues. While quan fiable clinical unmet need across mul ple diseases is s ll persists, unprecedented economic forces are re-defining the value of innova on and cure. Rising reimbursement hurdle in the west is leading to the development of specialized products primarily for niche, high value indica ons, such as cancer and hepa s. Furthermore, this phenomena is promp ng companies to focus only on those indica ons/countries (e.g. US) where pricing and reimbursement is viable and jus fies the cost of development. In this new economic reality, highly focused biotech/specialty Pharmaceu cal companies are able to rapidly gain commercial advantage, leaving big pharmaceu cal companies lagging behind. This dynamic presents problem (1) for large pharmaceu cal company growth in terms of accessing and valuing innova on (high demand, but limited supply), and (2) for developing countries, crea ng a long-term gap in affordable new drugs aimed at diseases of the developing world, which affect broad pa ent groups. At this juncture, it is clear that region-specific innova on should be high on the list for various countries, in order to balance the health needs of world. In an interes ng way, this phenomena provides opportuni es for regional entrepreneurs to make a significant impact on global health.
Innova on & Vaccine Hub of the World Dr. Krishna M. Ella
Dr. Krishna M. Ella, the Chairman and Managing Director of Bharat Biotech Interna onal Ltd, has graduated from the University of Agricultural SciencesBangalore, and the University of Hawaii and the University of Wisconsin- Madison. A er comple ng Ph. D from Madison, joined as faculty at the Medical University of South Carolina- Charleston. He moved to India during 1997 to set up Bharat Biotech. Bharat Biotech has invested more than USD 150 million towards facili es and projects, has sold more than 3 Billion doses in 65 countries. The company has created many new vaccines like Typhoid Conjugate Vaccine, Rotavirus. Under Social Innova on concept, Bharat entered public-private partnership with DBT, Bill & Melinda Gates Founda on, PATH, CDC-Atlanta, NIH-USA to develop ROTAVAC vaccine. Bharat Biotech was the first company in the developing world to conduct an Efficacy trial with a budget of USD 90 million. Recently ROTAVAC® the first novel vaccine which is completely developed in India was launched by our Hon'ble Prime MinisterBharat Biotech entered into a partnership with the University of Maryland to work on Non-Typhoid Salmonella (NTS) vaccines for Africa with a Grant of $ 4 Million from the Wellcome Trust. Bharat Biotech obtained more than 65 global patents with 8 new molecules. Both Bharat Biotech and Ella Founda on together published more than 90 research ar cles in peer review journals. The Ella Founda on is a non for profit organiza on purely focused on basic research in biological sciences with human and veterinary applica ons. He was Advisor to CM of AP for crea ng Knowledge Park which lead to Genome Valley which today created more than 10,000 jobs. Dr. Ella is ac vely involved in shaping India's science educa on and policy as well as Interna onal collabora on by being a Member, Advisor, and Chairman of numerous commi ees. Prominent among them are: he is the member of Governing Body of the Council of Scien fic and Industrial Research (CSIR); member of Scien fic Advisory Commi ee to the Cabinet (SAC-C); Chairman of Board of Governors of the Na onal Ins tute of Technology-Warangal. He served as Co-Chairman Indo-USA High Technology Coopera on Group (HTCG) for 5 years on behalf of Govt. of India and facilitated Knowledge Ini a ve Bill signed by USA. He received Interna onal guests like Hon President of USA -George Bush, Bill & Melinda Gates, the President of Gates Founda on, Hon. President of South Africa and Myanmar, Senator Kerry, and many interna onal visitors to Bharat Biotech. He received many awards such as Bio Spectrum Person of the year (2013); University of Wisconsin Dis nguished Alumni Award (2011); Business Leader of the Year (2011); Silver Patent Award from Government of India (2011); Best Entrepreneur Award – BioSpectrum, the Rotary Interna onal Fellowship; Best Technology and Innova on Award from the Prime Minister of India (2008); Asia Pacific Biobusiness Leadership Award 2005 from University of Southern California; Dr. K.C. Cha erjee – Memorial Award from Indian Pharmaceu cal Associa on, India (1999).
44
Abstract Indian vaccine industry has emerged as the poten al hub for vaccines for the world due to innova on and innova ve methods, sustained and uninterrupted supply of affordable, high quality vaccines to public vaccine markets globally. Innova on resulted in the development of new vaccines for Japanese Encephali s, Rotavirus from Indian strains, new conjuga on methods for vaccines against Typhoid and Meningococcus by the vaccine manufacturers of India. Sustained and uninterrupted supply of affordable, high quality vaccines to UNICEF and to the private markets of other countries by India is over 56% of the annual global requirements of vaccines. India is poised to become the Innova on and Vaccine Hub of the World due to its abundant skilled manpower and scien sts, adop on of leading edge technologies, ap tude for innova on in the development of new vaccines as the best public health interven on for the preven on and control of vaccinepreventable infec ous diseases.
Can India Sustain its Posi on as a Global Generics Provider Dr. Madhu Pudipeddi
Madhu Pudipeddi is a pharmaceu cal professional with a proven track record of metrics-driven performance in the area of “chemistry, manufacturing, and controls (CMC)”. He has excellent professional reputa on, global experience, cross-cultural awareness, strong people development skills, and outstanding scien fic excellence. Madhu has nearly 20 years of experience in pharmaceu cal development of new chemical en es and technical (manufacturing) opera ons of generic drug products. Madhu is currently Regional Head – Europe & India, Manufacturing, Science and Technology (Solid Dosage Forms) in Sandoz AG, Switzerland. Previously, he had held posi ons of increasing responsibility in Novar s Pharmaceu cals (USA & India) and Bristol-Myers Squibb (USA). He was awarded the pres gious Novar s Leading Scien st Award (Viva Award) in 2010 for his contribu ons in the area of Biopharmaceu cs in Drug Development. Madhu was one of the recipients of Thomas Alva Edison Patent Award in 2014 from the R&D Council of New Jersey, USA. Madhu has published several papers in the area of physical pharmaceu cs and formula on development. Madhu holds a Ph.D. in Pharmaceu cal Sciences from the University of Wisconsin, Madison, USA. He is Responsible for “MS&T – Solid Dosage Forms” func on for Region Europe & India. He had a Key leadership role in business case evalua on, site set-up, talent recruitment, reten on, and development and opera onal execu on. Managed complex global projects from early through late phase technical development. Led a team of nearly 100 associates organized in a team based nonhierarchical structure to deliver on organiza onal priori es. He won pres gious Novar s VIVA Leading Scien st Award in 2010
45
Abstract: A brief history of the evolu on of global generics business will be provided and the role of Indian Pharmaceu cals will be elaborated. The current status of global pharmaceu cal business will be reviewed, along with the contribu ons of Indian Pharma to the global generics market. Historical factors that contributed to the current significance of Indian Pharma in global generics and their relevance to future developments will be analyzed. Recent trends in the generic market field and upcoming loss of exclusivity (LOE) opportuni es will be examined. Examples of strategies by Generic companies for differen a on will be presented.
Business Poten al of Innova ve Pharmaceu cal Services vis a vis Pharmaceu cal Products Akash Mathur, Partner, Cardinal Points Consul ng
Akash Mathur did his MBA, Marke ng and corporate strategy, 1998 – 2000 in Washington University in St. Louis - Olin Business School; Ph D, Human Pathology, 1993 – 1998 in Saint Louis University; Master of Science (M.S.), Biophysics, 1988 – 1990 in All India Ins tute of Medical Sciences Abstract: A brief history of the evolu on of global generics business will be provided and the role of Indian Pharmaceu cals will be elaborated. The current status of global pharmaceu cal business will be reviewed, along with the contribu ons of Indian Pharma to the global generics market. Historical factors that contributed to the current significance of Indian Pharma in global generics and their relevance to future developments will be analyzed. Recent trends in the generic market field and upcoming loss of exclusivity (LOE) opportuni es will be examined. Examples of strategies by Generic companies for differen a on will be presented.
Role of Innova on in Generic Product Development Anirudh Gautam
Did his B. Pharm, Ins tute of Technology, Banaras Hindu University, Varanasi (India) in 1993 Later persued M. Pharm in Birla Ins tute of Technology & Science, Pilani (India) in 1995 and finally completed his Diploma in Opera onal Management (DOM) at Indra Gandhi Open University in 1999. 46
He was awarded the best poster award in 59th IPC, Varanasi for the category of Biopharmaceu cs, Pharmacokine cs and Drug Metabolism. He received a Cer ficate of Apprecia on in Ranbaxy for Team Excellence Award in 2006. He is the Topper of M. Pharm batch in 1995 He has done almost 20 PUBLICATIONS & PRESENTATIONS ll date He started his career as a Trainee Chemist-Produc on in Bri sh Health Products (I) Ltd., Dabur India Limited, Bhiwadi, Rajasthan. Later worked as Research Associate to Research Scien st, Clinical Pharmacology & Pharmacokine cs in Ranbaxy Research Laboratories. Then worked as Group Leader-Bioanaly cs, Wellquest Clinical Research, Nicholas Piramal. He is currently working as a Senior Research Scien st then Group Leader, Metabolism & Pharmacokine cs, Ranbaxy Research Laboratories and promoted to Associate Director in the same Company. He has Nineteen years of experience in differen ated formula ons development, generics research, drug discovery and development in therapeu c areas like neurology, dermatology, malarial, inflammatory diseases, arteriosclerosis and BPH He also has In-depth exposure in designing Bio studies for evalua ons of IR and NDDS formula ons, providing inputs as PK expert to product development teams and also has Rich experience of outsourcing preclinical and clinical ac vi es to Indian and Interna onal CROs; nego a ng me and money as well as developing them as strategic partners. Abstract: Innova on is the hallmark of science. The life sciences and pharmaceu cal science in par cular are no different. In colloquially sense generic product development may seem to be agnos c to innova on and has been looked down upon by innovator pharmaceu cal giants as science of copying and reverse engineering. Though the big and small generic players in the industry have been trying to proclaim their product development as exclusive and painstaking research work, they could seldom get it to the status of innova on. With the evolu on of newer and advance technologies in product development and their use, both for and against the barriers to generic entry, has led to the recogni on of novelty and originality in generic product development. The dread of patent cliff and the eluding breakthrough innova on in new drug discovery space has persuaded the Big Pharma to embrace generic product development as life cycle management of their own products. This phenomena has enthused greater play of innova on in generics business. The role of innova on in generic product development encompasses product per say to some extent, the process to a very large extent and supply management in the newest term. The abundance of dosage forms, routes and delivery systems of medicine for the treatment of whole array of disease condi ons provides ample prospects to revolu onise designing of generic pharmaceu cals of proven quality. Its great sa sfac on as a pharmaceu cal scien st to see that the ul mate beneficiary of the usage of excellent scien fic advances are the pa ents at large who get an access to affordable medicine.
47
Leveraging innova on to offer cu ng edge Pharmaceu cal Research Solu ons to Global Industry Manni Kan pudi
Manni Kan pudi is the Chief Execu ve Officer of GVK Biosciences and Inogent Laboratories. Prior to becoming the CEO, Manni was the President of GVK Biosciences from 2007 to 2010. Before joining GVK Biosciences, Manni spent 16 years with Intel Corpora on in various leadership posi ons in the US and Asia. Manni was responsible for se ng up Intel's engineering presence in India and headed up Intel India from 2000-2003. Manni was the CIO (Chief Informa on Officer) of Intel for Greater Asia from 2003-2004 and supported all Intel IT requirements for over 25,000 employees in Asia. Manni was Director of So ware for Intel's Wi-Fi Centrino product line from 2004-2007 where he brought to market successful products in high volume.
Opportuni es and Challenges in Biotechnology based products, and the Role India can play Dr. Mahesh Bhalgat Dr. Mahesh Bhalgat has over 25 years of experience in the field of biotechnology and biologics. Following the comple on of his B.Pharm from the University of Mumbai, Mahesh went to USA for advanced studies and obtained his Ph.D. in Medicinal Chemistry from the University of Utah. During his 20 year stay in the USA, his breadth of experience grew through working in many different func ons within the biotechnology industry. He has hands on experience working in the areas of Analy cal and Process Development, Opera ons, Regulatory Sciences and Quality. During the span of his career in the US, Dr. Bhalgat has worked in both small and large companies such as Amgen, Monsanto, Celera Genomics and Molecular Probes (now Invitrogen). A er returning to India, Mahesh started working in Biological E and is now Execu ve Director and Chief Opera ng Officer at Shantha Biotech. At Shantha, Mahesh is heading manufacturing, supply chain, quality and projects for the two facili es located in Hyderabad. Mahesh has experienced the diverse applica ons of biotechnology by working in biotherapeu cs, vaccines, agri-biotech, research reagents and more. During his illustrious career, Mahesh has contributed to the commercializa on of diagnos c kits, biopharmaceu cals including monoclonal an bodies and the WHO pre-qualifica on of vaccines.
48
Abstract: The modern-world biotechnology has grown substan ally and found applica ons in many complex processes such as manufacturing of vaccines that can eec vely help in control of complex medical condi ons, to the development of biotechnologically cured seeds that substan ally improve yields of crops across the world.The Indian biotech industry is among one of highest growth industries with signiďŹ cant opportuni es ahead. The presence of biotechnology solu ons in India has placed India amongst the top 12 biotech des na ons in the world and also ranks third in the Asia-PaciďŹ c region.Due to the mul -disciplinary nature of the solu ons applicable, biotechnology industry provides an opportunity for scien sts from many diverse backgrounds technologists to engage in driving progress in the use of biotechnology products and solu ons.
49
Day 4 (August 3) August
3
2015 Excursion Ras- Halls- Topaz, Diamond, Emerald, Turquoise, Coral
Day 4
Excursion: You will be taken on a tour to explore the city of Hyderabad. Places you will see Charminar Mecca Masjid Chowmahala Palace Golconda fort
Ÿ Ÿ Ÿ Ÿ
You can explore the rest of the city on your own during the free night. Dress Code: All the Par cipants must wear their congress T-shirts along with their IDs
Day 5 (August 4) 9:00 - 10:30 11:00 - 12:30 13:30 - 15:00
15:30 - 17:00
Day 5 August 4 2015 IPSF Clinical Skills Event Saree Draping-Exclusively Attitude to Altitude in Pharmacy Increasing the Introductory Workshop for Girls Profession Employability Quotient IPSF Patient Counseling Event - Turban Draping- Preferably Attitude to Altitude in Pharmacy Effective Documentation Introductory Workshop for Boys Prrofession Continous Manufacturing, IPSF Compounding Event Student Exchange OfficerEPSA-IPSF Workshop “Granulation”: An overview Introductory Workshop Workshop Pharmacy at Your Fingertips – Using Technology to Strengthen Your Therapy Decisions
IPSF 7 Minutes to Inspire
AMR: Clinical Skills & Awareness
GA
"Pharmaceutical R&D: New frontiers of innovation"
IPSF CLINICAL SKILLS EVENT - INTRODUCTORY WORKSHOP Venue: Topaz Hall Speaker: Mr. Nathan Ting, IPSF CSE Coordinator This workshop will define clinical skills focus on what it means to prac ce in a clinical se ng. In this workshop and in the compe on par cipants will have the opportunity to learn a systema c approach to iden fying and solving drug-related problems for their pa ents. The workshop will cover some basic tools that can be applied in your future prac ce as a pharmacist which can later be applied in the CSE compe ons. These basic skills will help provide a founda on for the par cipants who are interested in par cipa ng in the individual or the team compe on subsequent to the workshop. SAREE DRAPING-EXCLUSIVELY FOR GIRLS Venue: Amber Hall Workshop by RC Learn how to look like a Desi girl
50
ATTITUDE TO ALTITUDE IN PHARMACY PROFESSION Venue: Coral Hall Speaker: Dr. Mahesh Burande, President, Associa on of Pharmaceu cal Teachers of India Everybody want to become successful in life. To become successful Knowledge,skill,hard work and most important posi ve a tude is required to bring every dream in to reality. While achieving success there are many hurdles,problems,failures and even resistance from your surroundings. Once you develop posi ve a tude you take this obstacles as stepping stones in achieving your mission. This presenta on will illustrate many case studies in pharmacy profession who achieve highest peak in pharmacy profession in achieving the des na on. A tude to Al tude will inspire everybody to decide the big dream in pharmacy profession and road to reach to Everest in your own field. INCREASING THE EMPLOYABILITY QUOTIENT Venue: Turquoise Hall Speaker: Dr. Pradeep Desai, Advisory in- Management, Engineering and Commercializa on of Products, Solu ons, Services One of the thing that lingers in most peoples mind is how to get a good job. In a highly compe ve global world, ge ng gainfully employed and be successful is a challenge. Increasing the Employability Quo ent (EmQ) is important as it increases the chances of ge ng a job in alignment with the individual's interest. Employability Quo ent (EmQ) as i define, is a measure of preparedness towards ge ng employed. In this workshop we will discuss the various cons tuents of EmQ and how to increase the EmQ. We will also discuss the interview process and how to prepare for an interview. Effec vely managing the interview process is an integral part of increasing the EmQ. Increasing the EmQ has larger posi ve impact for the community and the economy. IPSF PATIENT COUNSELLING EVENT - INTRODUCTORY WORKSHOP Venue: Topaz Hall Speaker: Ms. Stephanie Miller This workshop will review the process of pa ent counselling and what it means to prac ce this in a clinical se ng. In this workshop and in the compe on par cipants will have the opportunity to prac ce these skills by counselling a pa ent actor. All pharmacists should use a systema c approach when counselling pa ents to ensure the medica on dispensed will be safe and effec ve for the pa ents. This approach shall be taught in the workshop and then prac ced in the event itself. TURBAN DRAPING- PREFERABLY FOR BOYS Venue: Amber Hall Workshop by RC 'Son of Sardar' or Pride of pagdi. Learn turban draping the desi-style EFFECTIVE DOCUMENTATION Venue: Turquoise Hall Speaker: Dr. Kaushik Desai, Hon.Secretary General, Indian Pharmaceu cal Associa on The Pharmaceu cal industry operates in a mul billion pounds / euros / dollars global market place. Its opera ons are highly complex and so are its regula ons. Proper understanding of documenta on principles is the crux to GMP in the pharmaceu cal industry. There is no stage in the life cycle of drugs that does not undergo regula ons and documenta on irrespec ve of whether it is the laboratory phase of a new molecular en ty discovery, tes ng in clinical trials, or the licensing, 51
manufacturing, and distribu on. It is impera ve to maintain a standard documenta on system for compliance to regulatory system. Good Documenta on Prac ces (GDP) assist in preven ng errors with various processes related to quality of drugs and the manufacturing facili es. There has been increasing regulatory oversight as compared to the past and many warning le ers are issued by Regulatory authori es worldwide based on improper records and documenta on. IPSF COMPOUNDING EVENT - INTRODUCTORY WORKSHOP Venue: Topaz Hall Speaker: Mr. Renato Nolasco, IPSF CE Coordinator The workshop will be an interac ve presenta on focussing on the art and prac ce of compounding pharmaceu cal formula ons. The presenta on will go over this history of compounding, what is important when compounding a pharmaceu cal product and a future perspec ve. Furthermore the par cipants of the workshop will be prepared for the compe on, where they can challenge their theore cal knowledge from pharmaceu cal technology and prac cal knowledge in compounding. IPSF-EPSA WORKSHOP Venue: Amber Hall Speaker: Mr. Jose Carvalho/ Katarzyna Świderek, EPSA President The Oxford dic onary defines 'Advocacy' as the 'public support for, or recommenda on of a par cular cause or policy'. Advocacy can take different forms and serve different purposes. In this workshop we will introduce tools used in advocacy and then we will work together on the areas of interest of pharmacy students, at local, na onal or in the case of EPSA (European Pharmaceu cal Students' Associa on) - European level. EPSA is a non-profit, non-poli cal organisa on, represen ng 160 000 pharmacy students from 35 countries across Europe. The Associa on exists to develop the interests and opinions of European Pharmacy Students and to encourage contact and coopera on between them. To understand advocacy on European level, we will go through European Union ins tu ons and their role in developing laws that concern every member in their everyday lives. Based on EPSA's example, we will discuss the differences between various levels of advocacy (local, na onal and European), but also how all layers can support each other and work towards the same goal. The workshop is targeted for par cipants eager to get to know and put into prac ce the approaches used when advoca ng for their interests, as well as the interests of their Associa ons on various levels. CONTINUOUS MANUFACTURING, “GRANULATION”: AN OVERVIEW Venue: Emrald Hall Speaker: Mr. Devashish Bakshi, Managing Director ,Tapasya Engineering works Pvt. Ltd The vision of con nuous manufacturing is of an industry with processes that are integrated, based on a systems approach, having model-based control, and making use of flow. Thus, seeing as a con nuous manufacturing process. The brief enlightenment of various approaches for con nuous manufacturing such as Hot Melt Extrusion, Roll Compac on, Top Spray Granula on with merits and demerits.
52
STUDENT EXCHANGE OFFICER- WORKSHOP Venue: Coral Hall Speaker: IPSF Execu ve Commi ee PHARMACY AT YOUR FINGERTIPS – USING TECHNOLOGY TO STRENGTHEN YOUR THERAPY DECISIONS Venue: Turquoise Hall Speaker: Eric Tan, Regional Sales Manager, Wolters Kluwer Clinical Drug Informa on IPSF 7 MINUTES TO INSPIRE Venue: Topaz Hall This session was developed based on the idea of IPSF Talk that was ini ated at the 59th IPSF World Congress in Utrecht, the Netherlands. "IPSF 7 Minutes to Inspire” will consist of interac ve sessions where par cipants are invited to give a 7-minute presenta on, speech, or even show to inspire the audiences to adopt new innova ve ideas or join a cause they passionately support. If you love TED talks, you will love this session. A panel of judges will be appointed to provide feedback to the par cipants' performance, and at the end of the session, the audiences will get the chance to vote on the Most Inspiring Par cipant. For par cipants, it is a great opportunity not only to share your ideas but also to develop your presenta on skills. AMR: CLINICAL SKILLS & AWARENESS Venue: Amber Hall Speaker: Ms. Lara Turiya Seitz, IPSF Medicine Awareness Coordinator "PHARMACEUTICAL R&D: NEW FRONTIERS OF INNOVATION" Venue: Coral Hall Speaker: Dr. Satya Lakshmi Orugan , Scien fic Manager Drug Repurposing Programme GVK Bioscience Pharma companies are con nuously being challenged by shrinking pipelines and rising costs of drug development which leads to the absolute necessity for innova on. Hence, for the pharma industry, it is a compulsion offering survival advantage. Innova on has been the mantra for most of the pharma companies in the form of novel target discovery, drug discovery, safer routes of administra on etc. However, recent mes have seen tremendous transforma on in nature and structure of the novel prac ces to meet pa ent, regulatory, healthcare and other stakeholder demands. Scope for transforma on in the pharma industry lies in two direc ons: one in the scien fic and technology aspects of crea ng treatments and the other in crea ng superior business models crea ng a win-win situa on for all the stakeholders such as investors, pa ents and the pharma company. 'Open Innova on' and 'Crowd sourcing' are two ideas that big pharma is embracing deeply for gaining a compe ve advantage over nimble start -ups. Big pharma as defined by giants such as Pfizer, Merck and Johnson and Johnson is marked by a growth pa ern which is o en inorganic, through mergers and acquisi ons. However, with the number of start-ups increasing consistently, the importance of size in innova on is being understood. The agility and flexibility of start-up environment is proven to foster innova on be er thus leading to a change in landscape. What exactly do we mean by the word 'innova on'? It is more o en a slow, incremental process that cannot be automated and mostly involves changing mindsets. It can be applied equally well to products, processes and organiza ons although the methods may vary dras cally. 53
Hence, transforming thought processes is the norm of the day and the only choice available for gaining compe ve edge. NEON PARTY Venue: Marrio Conven on Centre Dress Code: Lab coats, neon accessories. Things you will need: Markers, Fluorescent paint.
54
Day 6 (August 5) August 9:00 - 10:30 11:00 - 12:30 13:30 - 15:00 15:30 - 17:00
5
Day 6
2015
Industrial visit GA PHC Preparations
BREAKFAST Venue: Pearl Garden INDUSTRIAL VISIT Grab the chance to visit the pharmaceu cal industries in India. A endance is compulsory for all delegates (except the official delegates). Delegates will be divided into 5 groups and will get chance to share their views of different industries. The industries will be either of the following: (1) Lab India Analy cal Instruments (2) Sipra Labs (3) Natco Pharma Ltd. (4) Vimta Labs Ltd. (5) USP PHC PREPARATIONS Venue: Halls – Turquoise, Topaz, Opal, Amber, Coral Halls Lots of ac vity in store for Public Health Campaign on next day DINNER Venue: Shilparamam INDIAN NIGHT Venue: Shilparamam Desi, Desi, Desi….All the way Desi!
Day 7 (August 6) August
9:00 - 10:30
11:00 - 12:30
6 Public Health: Communicating in the IPSF Clinical Skills Event - Team Digital Age Competition IPSF Clinical Skills Event Case Presentation Competition
13:30 - 15:00 IPSF Patient Counselling Event Beginner Preliminaries 15:30 - 17:00
IPSF Patient Counselling Event - Advanced Preliminaries
Day 7
2015 Project Management Present needs of the Indian Pharma Industry from Academia The 3rd IPSF Young Researchers’ Forum I - World Café Discussion on Pharmacy Students Involvement in Research Projects The Great New Challenges facing the Pharmacists Worldwide in the New Millennium
PHC Group 1 -
RC Workshop - Reserved PHC Group 2 -
IPSF CLINICAL SKILLS EVENT - TEAM COMPETITION Venue: Diamond Hall Speaker: Mr. Nathan Ting, IPSF CSE Coordinator This workshop will define clinical skills focus on what it means to prac ce in a clinical se ng. In this workshop and in the compe on par cipants will have the opportunity to learn a systema c approach to iden fying and solving drug-related problems for their pa ents. The workshop will cover some basic tools that can be applied in your future prac ce as a pharmacist which can later be applied in the CSE compe ons. These basic skills will help provide a founda on for the par cipants who are interested in par cipa ng in the individual or the team compe on subsequent to the workshop. 55
PUBLIC HEALTH: COMMUNICATING IN THE DIGITAL AGE Venue: Emrald Hall Speaker: Mrs. Nirma Khatri Vadlamudi. Quality Specialist, Parexel. "According to an Ins tute of Medicine (2004) report, low health literacy nega vely affects the treatment outcome and safety of care delivery. Several studies reveal that up to half of pa ents cannot understand basic healthcare informa on. The mismatch between a clinician's level of communica on and a pa ent's ability to understand can lead to medica on errors and adverse medical outcomes. The lack of health literacy affects all segments of the popula on, although it is dispropor onate in certain demographic groups, such as the elderly, ethnic minori es, recent immigrants and persons with low general literacy. Pharmacist plays a key role in bridging the gap of lack of health literacy skills among pa ents and improper communica on with clinicians through health communica on. In this Public Health Communica on workshop, the instructor takes the par cipants through various behavior change theories, health message framing strategies, communica on styles to effec vely develop public health message for Direct Pa ent Care, Counseling or Public Health campaigns. Par cipants will get hands-on experience by working on real case studies". PROJECT MANAGEMENT Venue: Coral Hall Speaker: Mr. Murthy Chi oory, Vice-President, Venky Parenterals IPSF CLINICAL SKILLS EVENT - CASE PRESENTATION COMPETITION Venue: Emrald Hall Speaker: Mr. Nathan Ting, IPSF CSE Coordinator PRESENT NEEDS OF THE INDIAN PHARMA INDUSTRY FROM ACADEMIA Venue: Coral Hall Speaker: Dr. B. Prabha Shankar IPSF PATIENT COUNSELLING EVENT - BEGINNER PRELIMINARIES Venue: Diamond Hall Speaker: IPSF Execu ve Commi ee Member IPSF PATIENT COUNSELLING EVENT - ADVANCED PRELIMINARIES Venue: Emerald Hall Speaker: IPSF Execu ve Commi ee Member THE 3RD IPSF YOUNG RESEARCHERS' FORUM I - WORLD CAFÉ DISCUSSION ON PHARMACY STUDENTS INVOLVEMENT IN RESEARCH PROJECTS Venue: Amber Hall THE GREAT NEW CHALLENGES FACING THE PHARMACISTS WORLDWIDE IN THE NEW MILLENNIUM Venue: Coral Hall Speaker: Lt.Col. Prasad Tirunagaru, Lieutenant Colonel US Army. Lt. Colonel Prasad received his B.Pharm & M.Pharm degrees from Andhra University and Medical Service Core training as a combat pharmacist at the Academy of Health Sciences of US Army Medical department centre, Texas, USA. 56
The was the first South Indian to be commissioned as an officer in the US Army. He was the first foreigner to pass the pres gious California State Board Exams in the world. He has thirty five years of experience as a registered pharmacist in USA, as Assistant Chief and Chief of Pharmacy in various army medical centres. Special es include clinical research in developing human gene c insulin, nutri onal studies, in-pa ent and outpa ent pharmacies, oncology, chemotherapy and nuclear pharmacies. Developed hospital formulary, clinical training modules for healthcare professionals. The whole world is facing increasing economic impact of increased prices of medica on. Uncle Sam in USA, the Lords of London and the aging popula on in the whole world need help ge ng affordable quality medica on.
Day 8 (August 7) August 9:00 - 10:30
Gattefosse
11:00 - 12:30
Role of IPC in defining and maintaining quality standards of Medicines
7 2015 The National Health TRIPS and Post 2015: Service in the UK: The Opportunities to improve access Cost of Care and Future of to medicine Hospital Pharmacy Root Cause Analysis and CAPA system
Improving Patient Compliance by Formulation Design
13:30 - 15:00
IPSF Clinical Skills Event Individual Advanced
Model UNESCO
IPSF Clinical Skills Event Individual Beginners
15:30 - 17:00
Pharmacy Education Summit: Being the Ambassador for Change!
Model WHO
IPSF Training Opportunities
Day 8 Conflict Resolution in Workplace relationships Packaging Validation: A critical need to ensure valid product Pharmacovigilence: An eye for detail in ADR Management Quality Risk Management in Pharma Industry
GA Compounding event (from 13:00)
GATTEFOSSE VENUE:Coral hall. THE NATIONAL HEALTH SERVICE IN THE UK: THE COST OF CARE AND FUTURE OF HOSPITAL PHARMACY VENUE: Topaz hall. ABSTRACT: The UK prides itself on having one of the best healthcare systems in the world; the NHS (Na onal Health Service). In recent years there has been increasing stress on the NHS with li le investment from the government causing increased wai ng mes in A&E, understaffed and crowded hospital wards. Pharmacists are in a key posi on to develop their role to meet the sustained demand for a high quality health service under budget restraints. Hospital pharmacy is now exploring different avenues to s ll provide high quality care whilst not increasing costs of the service. A discussion on posi ves of hospital pharmacy in respec ve countries around the world will help built ideas for the future. TRIPS AND POST 2015: OPPORTUNITIES TO IMPROVE ACCESS TO MEDICINE VENUE: Opal hall. : CONFLICT RESOLUTION IN WORKPLACE RELATIONSHIPS VENUE: Amber hall. NAME OF THE SPEAKER::Dr. Samson Gandhi. ABSTRACT: A life that is not examined is not worth living. - Socrates Human rela onships are the essence of life - at home or at work. Harmony in rela onships is the joy of life. We all desire and strive to maintain peaceful rela onships. 57
However reality speaks a different line. Conflicts are part of our everyday work-life. We cannot wish them away. They are inevitable. Those that know how to resolve conflicts will enjoy work, and, therefore become more produc ve contribu ng to the bo om line of the company. Resolving conflicts is easier said than done. People are unique with different temperaments, come from contras ng cultures and operate in variety of situa ons. All these factors contribute to a complex work culture prone to conflicts. However, we learn to survive by adop ng different conflict resolu on strategies. These are picked up early in our life and modify them as we go along. At this seminar, you will be able to understand why we have conflicts in workplace rela onships. Then discover your own conflict resolu on style through a ques onnaire/instrument given to you. At this seminar, you will be able to understand why we have conflicts in workplace rela onships. Then discover your own conflict resolu on style through a ques onnaire/instrument given to you. Later, through a process of discussion you will be able to appreciate different conflict resolu on styles, understand why you choose a par cular conflict resolu on style and find out if there is one best conflict resolu on style. Come for a fun-way of learning. ROLE OF IPC IN DEFINING AND MAINTAINING QUALITY STANDARDS OF MEDICINES: VENUE: Emerald hall. NAME OF THE SPEAKER: Dr. Purandh sahu. ABSTRACT: Effec ve and safe use of drug can only be ascertained by the quality of drug. A goal; which every manufacturer try to achieve, maintain and every regulator try to ensure. This goal can be achieved only first by defining and guarding the path. That par cular path is shown & being guarded by Indian Pharmacopoeia Commission by defining various standards and parameters. These standards and parameters transcribed into a book of standards, 'Indian Pharmacopoeia'. For assuring quality of drugs, IP is published with regular updates, reflec ng the updates and changes in the technology and regula ons.IP conceptualize various parameters and test standards according to regional need. Another tool for ascertaining quality of drugs very finely is the Indian Pharmacopoeia Reference Standard (IPRS). In order to assure and verify the quality of medicines manufactured and marketed in India would require IPRS which act as a fingerprint for iden fica on, strength and purity of medicines. IPRS not only has the poten al to define as well as maintain the test standards which are very vulnerable to the varia ons that may arise at the hands of analyst, and various physical, chemical & even geographical condi ons, at a level where these can't be affected by the varia ons. ISO standards are being followed at Indian Pharmacopoeial Laboratory to provide bedrock to the scien fic literature published in IP and for assuring quality of IPRS. Safety of drugs ensured by quality but must be watched carefully at individual level keeping in mind individual varia on. Pharmacovigilance Programme of India being a part of IPC since 2011 has taken this endeavour. Na onal Formulary of India a book that describe proper and safe use of drugs to maximise benefit and minimise side effects of drugs NAME OF THE SESSION: Root Cause Analysis and CAPA system VENUE: Amber hall. NAME OF THE SPEAKER: Mr. Narendira Kumar ABSTRACT: Iden fying the root cause for market complaints, out of specifica ons (OOS), devia ons can be challenging, but a number of tools can help to inves gate the root cause so that correc ve and preven ve ac ons can be effec vely implemented. 58
FDA's Quality System Regula on as well as the new guidelines on “Quality Systems Approach to Pharmaceu cal Current Good Manufacturing Prac ce Regula ons” requires effec ve correc ve and preven ve ac ons (CAPA) with root cause analysis (RCA) as reac ve tool for system improvement to ensure that significant problems do not re-occur. The CAPA system is the most frequently inspected subsystem. No or inadequate procedures for correc ve and preven ve ac ons (CAPA) and missing root cause analyses are amongst the most frequently found devia ons in FDA warning le ers. Having compliant procedures for CAPA and compliant management is a must for any firm in the Medical Device manufacturer, Pharma Industry, regardless of marketplace. Successfully implemen ng and documen ng correc ve and preven ve ac ons (CAPA) is one of the cri cal processes in a medical device and pharmaceu cal manufacturing company's day-to-day quality opera ons. CAPAs carry significant implica ons for both product quality and compliance with FDA regulatory direc ves, and remain vital to any company's ability to address incidents that inevitably arise in the manufacturing processes. Due to this, it is cri cal to take necessary steps to prevent them from reoccurring. Root cause analysis is a completely separate process to incident management and immediate correc ve ac on, although they are o en completed in close proximity. The individual(s) tasked with ascertaining the underlying root cause must look beyond the obvious and make a serious a empt to pinpoint root cause. The good news is that there are tools available for inves gators to facilitate their quest for ascertaining root cause. Most regulatory bodies have similar requirements for CAPA and complaint management. NAME OF THE SESSION: Improving Pa ent Compliance by Formula on Design VENUE:Diamond hall. NAME OF THE SPEAKER:Mr. Shantanu Damle ABSTRACT: With evolving regula ons, the Pharmaceu cal Industry now needs to focus on Pa ent compliance as one of the most important Aspects while marke ng their product. There are new guidance documents from Regulators like US FDA indica ng Pa ent safety and Compliance being one of the important objec ve of companies launching any medica on. Though, it is a more of a company level ac vity and strategy, the onus ul mately comes on to the formula on Scien st to ensure that he/she makes the formula on not only in compliance to the regula ons, compendia, but also keep an eye on how to improve its compliance to the pa ents. This paradigm shi would change the way we approach our formula on development ac vi es and puts more focus on Safety by Design as part of development. The presenta on will cover various aspects on how pa ent compliance can be improved by use of simple techniques like Coa ng, Impact of size and shape of the dosage form to improve swallowability, taste masking of bi er tas ng drugs, limi ng the size of ER dosage forms etc. The ul mate aim of all these aspects would be to help reduce medica on errors, Ease of iden fica on, swallowability and palatability of dosage forms in – turn helping to improve the pa ent compliance. The presenta on will also talk of different Brand enhancement tools that help companies differen ate their dosage form in the crowded market and helps their product stand out from compe on.
59
NAME OF THE SESSION: Packaging Validation: A critical need to ensure valid product VENUE: Opal hall. NAME OF THE SPEAKER: Mr. Surender Manek ABSTRACT: In the Pharmaceu cal industry, GMPs are essen al to ensure that consistent quality products are manufactured and delivered to the pa ents. Valida on is now a Key requirement of all GMP Guidelines, as a validated process enables consistent manufacturing and packaging of products in accordance with the product quality and market requirements in a cost effec ve and secure manner. Various Valida on ac vi es required for a Pharmaceu cal products are captured in a Master Valida on Plan for the facility. It is observed that the Packaging Valida on perse is generally not specified as a separate valida on ac vity but considered as part of a Product Process Valida on ac vity and some aspects of it are covered during Process Valida on. Packaging valida on: It should form part of an overall Valida on program in the plant, to confirm that the resul ng product from a specified packaging process consistently conforms to product a ributes and the customer requirements. It is a risk-based approach, primarily focussing on the packaging processes that have the greatest poten al risk to product quality and thereby provides a ra onal framework for developing an appropriate scope for packaging valida on ac vi es. The Workshop will cover and highlight the need and the importance of Packaging valida on, its impact on the Quality of the products and key ac vi es to achieve it successfully. the greatest poten al risk to product quality and thereby provides a ra onal framework for developing an appropriate scope for packaging valida on ac vi es.The Workshop will cover and highlight the need and the importance of Packaging valida on, its impact on the Quality of the products and key ac vi es to achieve it successfully. NAME OF THE SESSION: IPSF CLINICAL SKILLS EVENT - INDIVIDUAL ADVANCED VENUE: Diamond hall. ABSTRACT: This workshop will define clinical skills focus on what it means to prac ce in a clinical se ng. In this workshop and in the compe on par cipants will have the opportunity to learn a systema c approach to iden fying and solving drug-related problems for their pa ents. The workshop will cover some basic tools that can be applied in your future prac ce as a pharmacist which can later be applied in the CSE compe ons. These basic skills will help provide a founda on for the par cipants who are interested in par cipa ng in the individual or the team compe on subsequent to the workshop. NAME OF THE SESSION: IPSF CLINICAL SKILLS EVENT - INDIVIDUAL BEGINNERS VENUE: Emerald hall. ABSTRACT: This workshop will define clinical skills focus on what it means to prac ce in a clinical se ng. In this workshop and in the compe on par cipants will have the opportunity to learn a systema c approach to iden fying and solving drug-related problems for their pa ents. The workshop will cover some basic tools that can be applied in your future prac ce as a pharmacist which can later be applied in the CSE compe ons. These basic skills will help provide a founda on for the par cipants who are interested in par cipa ng in the individual or the team compe on subsequent to the workshop. NAME OF THE SESSION: AN EYE FOR DETAIL IN ADR MANAGEMENT VENUE: Amber hall. NAME OF THE SPEAKER: Dr. Ramesh Adepu ABSTRACT: Medicines are being used to treat various illnesses as they have the ability to modify the altered physiological processes in the body. But at the same me, due to various predisposing 60
factors such as age, gender, co morbidi es, poly pharmacy and gene c pre disposi on,o en medicines pose certain amount of risk in the form of unwanted effects that are known as adverse drug reac ons (ADRs) and causes morbidity and mortality. The burden of ADRs is first known to the world through Thalidomide disaster in 1960's. Many research studies further have corroborated the high incidence and severity of the problem posing risk to general wellbeing and increased health care expenditure. New drug molecules are being introduced in to the market based on efficacy and safety evidences. However during the post marke ng, o en pa ents experience adverse events due to various predisposing factors. Pharmacovigilance (PV) is a scien fic studythat detects, assesses, understands and preventsthe adverse effects or any other drug-related problem. Spontaneous repor ng system is an easy, convenient and economical method o en used by health care professionals to report ADRs. Many countries encourage pharmacists to report ADRs. The Uppsala monitoring center (UMC) is the opera onal arm of the WHO Interna onal Drug Monitoring program.UMC collects global ADR data, especially from WHO interna onal drug monitoring program member countries.In India, Pharmacovigilance Program of India (PvPI) generates an independent data on the safety of medicines. Health care professionals use PvPI ADR repor ng forms to collect the informa on on adverse drug reac ons from pa ents. Completely and accurately filled ADR no fica on forms may be sent to local ADR Monitoring centers (AMC) for further evalua on and processing. NAME OF THE SESSION: PHARMACY EDUCATION SUMMIT: BEING THE AMBASSADOR FOR CHANGE! VENUE: Diamond hall. NAME OF THE SESSION: MODEL WHO VENUE: Emerald hall. ABSTRACT:In this session there will be a simula on of the World Health Assembly. Each delegate will represent a country and some background research on the topic provided will be necessary. Delegates will follow the rules of WHA such as speaking order, me given to speak, among others. NAME OF THE SESSION:IPSF TRAINING OPPORTUNITIES VENUE: Topaz hall. ABSTRACT:A er the introduc on of TRIPS, the world of healthcare has hit heavily as developing countries were ge ng limited access to healthcare. In order to improve the public health stature of the developing countries, paragraph 6 of the Doha Conven on of WTO, popularly known as 'Doha Declara on' has given the developing countries a golden opportunity to manufacture their own medicine in addi on to expor ng to other developing countries without TRIPS ll a period of 2015. This par cular declara on has effected greatly on some of the developing countries, developing medicines of excellent quality to improve the public health stature of the locality as well as expor ng to the developed countries by mee ng their quality standard entering stringent drug market. The interes ng query can come to the mind, as 2015 is drawing near end, how the developing countries will be able to cope with it and the subsequent changes that would take place in the world of healthcare.
61
NAME OF THE SESSION:QUALITY RISK MANAGEMENT IN PHARMA INDUSTRY VENUE: Amber hall. NAME OF THE SPEAKER: Mr. Narendira Kumar ABSTRACT: Risk management principles are effec vely u lized in many areas of business and government including finance, insurance, occupa onal safety, public health, pharmacovigilance, and by agencies regula ng these industries. Although there are some examples of the use of quality risk management in the pharmaceu cal industry today, they are limited and do not represent the full contribu ons that risk management has to offer. In addi on, the importance of quality systems has been recognized in the pharmaceu cal industry and it is becoming evident that quality risk management is a valuable component of an effec ve quality system. It is commonly understood that risk is defined as the combina on of the probability of occurrence of harm and the severity of that harm. However, achieving a shared understanding of the applica on of risk management among diverse stakeholders is difficult because each stakeholder might perceive different poten al harms, place a different probability on each harm occurring and a ribute different severi es to each harm. In rela on to pharmaceu cals, although there are a variety of stakeholders, including pa ents and medical prac oners as well as government and industry, the protec on of the pa ent by managing the risk to quality should be considered of prime importance. The manufacturing and use of a drug (medicinal) product, including its components, necessarily entail some degree of risk. The risk to its quality is just one component of the overall risk. It is important to understand that product quality should be maintained throughout the product lifecycle such that the a ributes that are important to the quality of the drug (medicinal) product remain consistent with those used in the clinical studies. An effec ve quality risk management approach can further ensure the high quality of the drug (medicinal) product to the pa ent by providing a proac ve means to iden fy and control poten al quality issues during development and manufacturing. Addi onally, use of quality risk management can improve the decision making if a quality problem arises. Effec ve quality risk management can facilitate be er and more informed decisions, can provide regulators with greater assurance of a company's ability to deal with poten al risks and can beneficially affect the extent and level of direct regulatory oversight. .
62
Day 9 (August 8) 9:00 - 10:30
11:00 - 12:30
13:30 - 15:00
15:30 - 17:00
Day 9 8 2015 Pharmacokinetics and its IPSF Patient Counselling Event - How to Run an Innovative applications Finals Public Health Career opportunities in Engaging Pharmacy Students in Regulatory Affairs utilizing IPSF Clinical Skills EventHow to Run an Innovative Public Health Activities knowledge of Regulatory Jeopardy Public Health Sciences Herbal formulation industry in Mrs. Archana Mugdhal workshop Challenges of Membership GMP - Recent Trends and India: Challenges and - Waiting for conďŹ rmation Promotion developments opportunities Pharma Research: IndustryStrategies for writing Academia-Regulatory Concern, Research Methodologies Pediatric Pharmacy research paper case Studies August Good practices in pharmaceutical industry
GA
GOOD PRATICIES IN PHARMACEUTICAL INDUSTRY. VENUE: Coral hall SPEAKER: Dr.Abdul bari. ABSTRACT: Good prac ces like GMP and GLP are necessary condi ons for marke ng authoriza on of pharmaceu cal products globally. A number of countries require manufacturers of industrial chemicals, pharmaceu cals, veterinary drugs, pes cides, cosme c products, food products, feed addi ves, etc., to establish through data that use of these products do not pose any hazards to human health and the environment. Good prac ces require major investments in upgrading manufacturing facili es to comply with interna onal rules and standards. Good prac ces in produc on and quality control, provides guidance on ac ons to be taken separately by produc on and by quality control personnel for the implementa on of the general principles of QA .Good prac ces needs to be established through studies and data, which will be examined by the regulatory authori es of the concerned countries. Good Laboratory Prac ce (GLP) is a system, which has been evolved by Organisa on for Economic Co-opera on and Development (OECD) used for achieving the above goals. Indian small pharma industries should be aware of the good prac ces to reach globally. PHARMACOKINETICS AND ITS APPLICATIONS VENUE: Amber hall. SPEAKER: Prof. K. P. R. Chowdhary ABSTRACT: Pharmacokine cs is the study of kine cs of absorp on, distribu on, metabolism and elimina on (ADME) of drugs in the body. The disposi on of the drug in the body is mathema cally described by various kine c models. The knowledge of pharmacokine c is useful in es ma ng dosage and dosage schedules; in the design of controlled drug delivery systems; in iden fying drug drug interac ons; in dosage adjustments; in therapeu c drug monitoring and for comparing drug products. The principles of pharmacokine cs, compartment models pharmacokine cs parameters, their assessment and applica ons and case studies illustra ng the applica ons of pharmacokine cs are discussed in this presenta on. IPSF PATIENT COUNSELLING EVENT - FINALS VENUE: Diamond hall. SPEAKER: Stephanie Miller ABSTRACT: This workshop will review the process of pa ent counselling and what it means to prac ce this in a clinical se ng. In this workshop and in the compe on par cipants will have the opportunity to prac ce these skills by counselling a pa ent actor. All pharmacists should use a systema c approach when counselling pa ents to ensure the medica on dispensed will be safe and eec ve for the pa ents. This approach shall be taught in the workshop and then prac ced in the event itself. 63
HOW TO RUN AN INNOVATIVE PUBLIC HEALTH VENUE: Emerald hall. SPEAKER: IPSF Execu ve Commi ee ENGAGING PHARMACY EDUCATION IN PUBLIC HEALTH ACTIVITIES. VENUE: Amber hall SPEAKER: Mrs. Manjiri Gharat ABSTRACT: Public health ini a ves emphasize the preven on of diseases. It recognize the health needs of the popula on as a whole and availability of the quality health and disease preven on services. Worldwide, Community pharmacies provide a range of public health services with promising improvements in health access and outcomes. The budding pharmacists also can play important role in public health improvement right from their student phase. Public oriented ac vi es not only gives them an insight in the real health issues of the society but also overall enhances the interest in pharmacy educa on and its applica ons for the society. The presenta on discusses the posi ve and inspiring experiences of engaging pharmacy students in Tuberculosis Control ac vi es, Medicine Literacy campaigns and few other community service ac vi es. CAREER OPPORTUNITIES IN REGULATORY AFFAIRS UTILIZING KNOWLEDGE OF REGULATORY SCIENCES VENUE:Topaz Hall. SPEAKER: Dr. Subhash C. Mandal ABSTRACT: A Pharmacy Graduate or Post Graduate in pharmacy may opt for different specializa ons like-Research, Manufacturing, Quality Control, Quality Assurance, Marke ng etc. Generally they get exposure in the selected field only. A manufacturing Pharmacist generally gets opportunity to manufacture a single category, if not so fortunate to get exposure to all types of manufacturing. Similarly a QC Pharmacist gets hardly any exposure in other areas like manufacturing, sales etc. But a Pharmacist op ng for Regulatory Affairs requires handling of Manufacturing, Quality Control, Product Development, Clinical Trial, and Quality Assurance of medicines. He needs to handle not only Allopathic medicines, but also other systems like Ayurvedic including Siddha, Unani and Homoeopathy also. A regulatory Pharmacist requires to be an expert on Blood Banks, Medical Devices, Cosme cs etc. as these are integral part of func oning under FDA. Being a regulatory personnel, a pharmacist needs to handle Import and export ma ers and thus must be an expert in this ma er –requiring to be conversant with the regulatory mechanisms like-ICH, USFDA, EDQM, MCA, TGA, WHO cer fica on etc. Regulatory personnel not only deal with Drugs and Cosme cs Acts, but also deal with other related laws like- IPR, Paten ng, Copy Rights and Trade Marks, DPCO etc.. This is very important in case of introduc on of a new product and even introduc on of Generics in other countries. Therefore, RA covers a vast area in the pharmaceu cal profession, providing immense opportunity of work. Addi onally, there is tremendous scope for Regulatory personnel in Pharma Industry throughout the Globe. IPSF CLINICAL SKILLS EVENT- JEOPARDY VENUE: Diamond hall. Abstract: This workshop will define clinical skills focus on what it means to prac ce in a clinical se ng. In this workshop and in the compe on par cipants will have the opportunity to learn a systema c approach to iden fying and solving drug-related problems for their pa ents. The workshop will cover some basic tools that can be applied in your future prac ce as a pharmacist which can later be applied in the CSE compe ons. These basic skills will help provide a founda on for the par cipants who are interested in par cipa ng in the individual or the team compe on subsequent to the workshop. 64
“ SKILL DEVELOPMENT WORKSHOP - BRIDGING THE GAP BETWEEN ACADEMY AND PHARMA INDUSTRY" VENUE: Amber Hall SPEAKER: Dr . M.Venkata Reddy, Director, Hitech Inst. of Adv. Pharmaceu cal Sciences Globally pharmacy profession and educa on are undergoing unprecedented change as the role of the pharmacist as a provider of healthcare services is increasingly recognized, valued, and expanded. Many countries are however, faced with cri cal shortages of skilled pharmacy workforce. In this world of specializa on and globaliza on, the pharmacy educa on in India is suffering from serious backdrops and flaws. The main reason for the setback is due to the curriculum followed by most of the universi es which is not up to the mark, but the poten al for growth of pharmacy profession is enormous if we upgrade our standards of educa on to the global expecta ons. The gap between academy and pharma industry has to be properly bridged by providing systema c industry oriented prac cal training. This skill development programmes will enhance the knowledge of budding pharmacists for be er opportuni es. Further similar to the quality assurance which Pharma industries give for the drugs they manufacture as a statutory requirement, Pharmacy ins tu ons shall also give assurance for the quality of educa on they provide. CHALLENGES OF MEMBERSHIP PROMOTION VENUE: Topaz hall. Abstract: Promo ng the Federa on to non-members countries and universi es is the only way to achieve the worldwide representa on of the Pharmacy Students. Nevertheless, promo ng and adding new members to IPSF is heavily influenced by Social, Economic, Poli cal, Ideological and Historical ques ons of the country. Therefore, an analysis of those subjects are essen al for developing the IPSF representa on not only in PARO, but also in the whole world. HERBAL FORMULATION INDUSTRY IN INDIA: CHALLENGES AND OPPORTUNITIES VENUE: Diamond hall NAME OF THE SPEAKER:Mr.Abdul bari. Abstract: India also known as the medicinal garden of the world as rich source of medicinal plants available in India. India with ancient civiliza on is s ll u lizing herbs for curing diseases for safety and cultural acceptability in the name of Ayurveda,Siddha,Unani and yoga. Tradi onal Medicine will contribute to human health care in the 21st century. The new genera ons and researchers should take care of this ancient knowledge of herbs to produce excellent delivery systems. There is an urgent need for Indian research to focus on the areas of quality, documenta on, standardiza on and clinical evidence. Evalua on of tradi onal medicines on scien fic ground is challenging and thrust area. We should focus on measures to be adopted for global promo on of Indian herbal products in terms of Nutraceu cls, Cosmeceu cals, and Dietary supplements and also Bulk herbal extracts. The herbal companies should comply with global standers (WHO GMP) for manufacturing of herbal drugs under GLP and GMP condi ons. Herbal industries, research ins tutes, Indian pharmacopeia commission and AYUSH departments should work together to develop new technologies for promo ng exports. Time has to come to accept the same synthe c drug regula ons for herbal remedies. The golden dictum for herbal medicines is “Effec ve Regula ons Improve Research” 65
GMP - RECENT TRENDS AND DEVELOPMENTS VENUE: Emerald hall. SPEAKER: Mr. Amaresh Tumbagi, Deputy Drug Controlller, Karnataka State PHARMA RESEARCH: INDUSTRY-ACADEMIA-REGULATORY CONCERN, CASE STUDIES Venue: Amber hall. SPEAKER: Dr. P.G. Shrotriya, Director, Pharma Research, SPTM-NMIMS Pharma Research is in the Centre of a having Industry - Academia and Regulatory Compliance in the three angle with Govt. Policy and Pharmacy Students in the arms. It covers Influence of Govt. Policy on Development of Pharma Research and Industry Interna onally. Role of Academia cannot be undermined as a Bank of Human Resource. The main reason for the setback is due to the curriculum followed by most of the universi es which is not up to the mark, but the poten al for growth of pharmacy profession is enormous if we upgrade our standards of educa on to the global expecta ons. The gap between academy and pharma industry has to be properly bridged by providing systema c industry oriented prac cal training. This skill development programmes will enhance the knowledge of budding pharmacists for be er opportuni es. Further similar to the quality assurance which Pharma industries give for the drugs they manufacture as a statutory requirement, Pharmacy ins tu ons shall also give assurance for the quality of educa on they provide. CHALLENGES OF MEMBERSHIP PROMOTION VENUE: Topaz hall. Abstract: Promo ng the Federa on to non-members countries and universi es is the only way to achieve the worldwide representa on of the Pharmacy Students. Nevertheless, promo ng and adding new members to IPSF is heavily influenced by Social, Economic, Poli cal, Ideological and Historical ques ons of the country. Therefore, an analysis of those subjects are essen al for developing the IPSF representa on not only in PARO, but also in the whole world. HERBAL FORMULATION INDUSTRY IN INDIA: CHALLENGES AND OPPORTUNITIES VENUE: Diamond hall NAME OF THE SPEAKER:Mr.Abdul bari. Abstract: India also known as the medicinal garden of the world as rich source of medicinal plants available in India. India with ancient civiliza on is s ll u lizing herbs for curing diseases for safety and cultural acceptability in the name of Ayurveda,Siddha,Unani and yoga. Tradi onal Medicine will contribute to human health care in the 21st century. The new genera ons and researchers should take care of this ancient knowledge of herbs to produce excellent delivery systems. There is an urgent need for Indian research to focus on the areas of quality, documenta on, standardiza on and clinical evidence. Evalua on of tradi onal medicines on scien fic ground is challenging and thrust area. We should focus on measures to be adopted for global promo on of Indian herbal products in terms of Nutraceu cls, Cosmeceu cals, and Dietary supplements and also Bulk herbal extracts. The herbal companies should comply with global standers (WHO GMP) for manufacturing of herbal drugs under GLP and GMP condi ons. Herbal industries, research ins tutes, Indian pharmacopeia commission and AYUSH departments should work together to develop new technologies for promo ng exports. Time has to come to accept the same synthe c drug regula ons for herbal remedies. The golden dictum for herbal medicines is “Effec ve Regula ons Improve Research” 66
GMP - RECENT TRENDS AND DEVELOPMENTS VENUE: Emerald hall. SPEAKER: Mr. Amaresh Tumbagi, Deputy Drug Controlller, Karnataka State PHARMA RESEARCH: INDUSTRY-ACADEMIA-REGULATORY CONCERN, CASE STUDIES Venue: Amber hall. SPEAKER: Dr. P.G. Shrotriya, Director, Pharma Research, SPTM-NMIMS Pharma Research is in the Centre of a having Industry - Academia and Regulatory Compliance in the three angle with Govt. Policy and Pharmacy Students in the arms. It covers Inuence of Govt. Policy on Development of Pharma Research and Industry Interna onally. Role of Academia cannot be undermined as a Bank of Human Resource.
67
Our Supporters We would like to thank all our Sponsors for their support. Without them our this event would not have been possible.
Industry Associate:
Technical Support:
Reverb IT Solutions
Teach Global Solutions Pvt. Ltd.
Silver Sponsor:
Gattefosse India Ltd.
Symposia Partner
ScientiďŹ c Partner
Event Sponsor
R. L. Fine Chem
Indian Pharmaceutical Association
Tamil Nadu IPA Trust
68
Indian Pharmaceutical Association IPA Bengal Pharma and Healthcare Trust
69
Media Partner
Indian Pharmaceutical Association
Supporting Media Partner
The Indian Pharmacist
IPA Pharmatimes
Transport Partner £ CMR COLLEGE OF PHARMACY, HYDERABAD £ VISHNU INSTITUTE OF PHARMACEUTICAL
EDUCATION AND RESEARCH, HYDERABAD
70
Cito Healthcare Pvt Ltd is a pharmaceutical and healthcare industry services company with four vertical objectives: ® ® ® ®
Product Sourcing covering bulk actives, intermediates, pharmaceutical formulations, neutraceuticals etc. Project Sourcing including clinical trials encompassing pre-clinicals, proof of concepts, CEPs, bioequivalence, early stages like phase-I and late stages Academic collaborations for student exchange, faculty exchange, twinning of programme. Training encompassing GxP and placement founded by Mr.Sankara V Krishna Prasad in 2010,
The company has made its mark in various areas some of which are the following: ®
® ®
® ® ® ® ®
® ® ®
®
Won Healthcare Delivery Excellence Award for Marketing & Business Development from Indus Foundation, New Jersey at the Indo Global Healthcare Summit & Expo 2014, presented by the Hon'ble Healthcare Minister, Telangana on 22nd June 2014. Organizing Committee Member – Indus Foundation Healthcare and Education Summits & Expos
Organizing Committee Member – Omics Group Internationals Conferences & ExposOrganizing Committee Member – Omics Group Internationals Conferences & Expos - Pharma Industry Co-ordinator - Industrial Development Forum Associate of Pan IIT organization for their industry interphase especially in pharma sector. Tied up with an associate for the Annual Conference of IIT 2014 for Scientific Content Partnership Efforts are on to bring alliance among Pharmexcil and AAPS, GPhA of USA Brought together the Indus Foundation and Pharmexcil Brought together the Omics and Indus Foundation Brought an alliance between competing CROs to complement (based on clinical and analytical strengths in the BA/BE space) Coordinator –Drugs & Pharmaceuticals-IDF. Instrumental in getting Pharmexcil and IDF together to liase with the Govt of Andhra Pradesh and ensured allocation of 10 acres of land for Pharmexcil and allied offices at Visakhapatnam. Co-chair, Press and Publicity, 66th IPC, Hyderabad. Instrumental in getting the Telangana Government associate with the event and participate Panel speaker at CII, AP's meet on Logistics in the state of Andhra Pradesh in the presence of Japanese delegation at Vijayawada. Conference Chairman, CII, Institute of Logistics, “Healthcare Supply Chain” coordinating with the knowledge partner Tata Strategic Management Group to plan the conference, for the proposed one in 2015 at HICC. Minster for Health, Telangana is being brought as the chief guest apart from an array of speakers spanning manufacturing, courier organisations, regulators, researchers and other service providers. Industry Associate, 61st IPSF World Congress 2015, Hyderabad
For more information, please refer to www.citohealthcare.com
71
With Best Compliments From
72
With Best Compliments From
Gattefosse India Ltd.
73
74
With Best Compliments From
75
76
77
With Best Compliments From
A.M. Reddy Memorial College Of Pharmacy
78
With Best Compliments From
(APTI)
79
80
81
“If you don’t build your dream,
hire you to help them build theirs.” someone
else
will
Wish the great success for “61st IPSF World Congress” Indian Pharmaceutical Association M.P. State Branch, Indore 104,ShrinathNiketan, 29,SnehlataGanj, Indore (M.P.)
82
With Best Compliments From
K.C REDDY INSTITUTE OF PHARMACEUTICAL SCIENCES Jangamguntlapalem (P), Medikonduru (M),Guntur-522438, A.P Ph: 08641-239498, 9441215475. Email: kcr_bpharmacy@yahoo.com, Website: www.kcr.ac.in
Approved By AICTE & PCI - New Delhi Affiliated to Acharya Nagarjuna University, Guntur Courses Offered: § B.PHARMACY § M.PHARMACY ü Pharmaceutics ü Pharmaceutical Analysis & Quality Assurance
ü Pharmacology
Dr.D.SRINIVASA RAO M.Pharm., Ph.D
Principal & Professor
83
With Best Compliments From
84
85
86
87
With Best Compliments from
Shreyaas Health Care
88
89
90
91
92
93
With Best Compliments From
94
95
96
With Best Compliments From
97
Special Thanks For Supporting Public Health Campaign
& Zilla parishad High School, Kukatpally Auxilium High School, Mahindra Hills
Special Thanks For Supporting Industrial Visit
¢ ¢ ¢ ¢ ¢
United States Pharmacopoeia Lab India Analytical Instruments Sipra Labs Ltd. NATCO Pharma Ltd. Vimta Labs Ltd.
98
99
With Best Compliments From
Contact Person:Mr. Srinivas (Marketing Manager) Contact Number:+91-22-28643481 Address:10/D, 2nd Floor, Matru Ashish Building, Near Balbharti School, S V Road, Kandivali (W), Mumbai,Maharashtra, India.
100
101
MAM College Of Pharmacy
Creative Education Society’s College of Pharmacy
S Institute of Pharmaceutical Sciences 102
Vignan Pharmacy College
Talla Padmavati College of Pharmacy
103
Certainant Infrastructures PVT LTD Certainant is an infrastructure development company providing end to end real estate solutions. We bring in our innovation, experience and expertise together to create optimal living spaces of enduring value to our clients. Certainant builds deserving homes with ful l spectrum of lifestyle you rightfully deserve.
Mr Ajay - +919740899250 OfďŹ ce address - No.205 1st Floor, JSA Towers, Double Road Indiranagar 2nd Stage, Bangalore-560038 Tel : +918067651000 Mobile 8884439184/8884439187 Email : sales@certainant.coma Web - www.certainant.com
Durgadevi Motors Owner: Nandkumar K Panickar Phone : +91 9820141689 Address : Elphinstone Road. Mumbai - 25 Manufacturers of Truck and Bus radials, Car tyres, etc.
104
With Best Compliments From
Factory Address: J-174, M.I.D.C.,Tarapur, Boisar, Thane - 401 506 TeleFax : +91 02525 270561 / 272129
OfďŹ ce Address: A/101, Prathna Apartment, Plot No. 15, Jawahar Nagar, S.V.Road, Goregaon (West) Mumbai - 400 062 INDIA TeleFax : +91 22 28725367 / 28738643 / 28773023 Email: info@samrudhpharma.com
105
List of Advertisements
Page
Cito Healthcare
72
TSIIC
73
Ga efosse
74
Dr. Reddy’s Laboratories
75
Mylan, India
76
Omics Interna onal
77
54th IPC Trust
78
A.M. Reddy Memorial college of pharmacy
79
Associaton of Pharmaceu cal Teachers of India
80
Chebrolu Hanumaiah Ins tute of Pharmaceu cal Sciences
81
Ins tute of Pharmaceu cal Educa on and Research
82
Indian Pharmaceu cal Associa on M.P. State Branch, Indore
83
K.C. Reddy Ins tute of Pharmaceu cal Sciences
84
KLR Pharmacy College
85
Narasraopeta Ins tute of Pharmaceu cal Sciences
86
Pra shta Ins tute of Pharmaceu cal Sciences
87
Pulipa
88
Prasad College of Pharmaceu cal sciences
Shreyas Healthcare
89
Siddhartha College of Pharmaceu cal Sciences
90
Sri Indu Group of Educa onal Ins tu ons
91
Sri Padmawa
92
School of Pharmacy
Surabhi Educa onal Society
93
St. Peters Ins tute of Pharmaceu cal Sciences
94
Suven Life sciences
95
Vikas College of Pharmaceu cal Sciences
96
Vikas Ins tute of Pharmaceu cal Sciences
97
Lupin
98
Florance old age home & Medical Services
100
Ins tute of Pharmaceu cal Training
100
Devson Impex Pvt. Ltd.
100
Synpure labs india pvt ltd.
101
JPN Pharma Pvt. Ltd.
101
Praga
102
house of pharma machineries
MAM college of pharmacy
103
Chitkara university
103
Crea ve Educa on Society’s College of Pharmacy
103
Srinivasa ins tute of pharmaceu cal sciences
103
Sri Venkateshwara c.k college of pharmacy
104
Vignan pharmacy college
104
Talla Padmava college of pharmacy
104
Sree Chaitanya inistute of Pharmaceu cal Sciences
104
Certainant Infrastructures Pvt. Ltd.
105
Durgadevi Motors
105
Samrudh Pharmaceu cals
106